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Abstract 
 
Gene expression is controlled by regulating both protein and chromatin modifications involved in the initiation 
of transcription. The regulation of gene expression consists of a series of events finally leading to the initiation of 
transcription. These events include several protein associations and dissociations in the regulatory regions of 
genes in addition to many protein-protein interactions and chromatin modifications. The main players in this 
system are the RNA polymerase II (Pol II), for polyadenylated messenger RNAs and numerous transcription 
factors (TFs), co-regulators and chromatin modifying enzymes. 
 
The main objective of this study was to gain more information on the mechanisms of gene regulation on the 
chromatin level using as an example of two genes, human hyaluronan synthase 2 (HAS2) and human CYCLIN C. 
The human HAS2 gene is regulated by the TFs retinoic acid receptor (RAR), signal transducer and activator of 
transcription (STAT), nuclear factor κB (NF-κB) and cAMP-response element binding protein 1 (CREB1). In 
addition, we demonstrated that the responses are mediated via response elements (REs) for corresponding TFs 
located within the first 2,250 bp of the human HAS2 promoter and that each RE recruits a different pattern of 
transcriptional regulators in response to different stimuli. We showed that the human CYCLIN C gene was also 
regulated by RAR and CREB1. The co-regulator recruitment to REs for RAR and CREB1 (RAREs and CREs, 
respectively) and to the vitamin D receptor (VDREs) was unique for each RE is response to different stimuli. The 
different TFs were also shown to interfere with each other both on mRNA and chromatin level. This interference 
suggests integration of different signaling pathways via the use of common co-regulators. 
 
In conclusion, the studies presented in this doctoral thesis provide new information about the regulation of two 
important genes, human HAS2 and CYCLIN C, and more detailed understanding of the mechanisms of the gene 
regulation on the chromatin level. 
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1. Introduction 
 
Every cell is continuously exposed to stimuli from the extracellular environment. In order to survive in this 
changing environment, cells need to respond to those stimuli in a highly co-ordinated and accurate way. All cells 
of an organism are of same origin, the fertilized egg, so they contain the same genetic material, their genomic 
DNA, which stores and transmits the genetic information. In humans, the genome is formed by more than 20,000 
genes and a lot of repetitive sequences. The genes are the templates for producing the functional units of a cell, 
mostly proteins. Individual cell types are characterized by which proteins it produces, i.e. which genes are first 
transcribed into mRNA and then translated into proteins. Therefore, although the genomic material is the same in 
each cell, cells are unique how they recognize and respond to environmental changes. The changing environment 
requires that a cell changes its protein synthesis, that is regulates the gene expression, which is the process that 
transfers the information from the genomic DNA via transcription and translation to proteins. This means that 
gene transcription also has to be a dynamic process. 
 
The regulation of gene expression is under tight control. At its start, gene transcription is a result of well-co-
ordinated actions of several regulatory proteins. In addition to a wide range of protein co-factors, a proper 
chromatin conformation is also required for transcription initiation. The activation state of chromatin is regulated 
by histone-modifying enzymes and chromatin-remodeling complexes. A host of proteins necessary to 
transcription initiation are assembled on to Pol II, the general TFs, co-activators (CoAs), co-repressors (CoRs), 
chromatin remodelers, histone acetyltransferases (HATs), histone deacetylases (HDACs) and histone methylases 
(HMTs). Activation of transcription requires the binding of specific TFs to their REs following the opening of 
chromatin, the binding of co-regulators and finally the assembly of the pre-initiation complex with Pol II to 
initiate RNA synthesis. 
 
Nuclear receptors (NRs) are ligand-activated TFs that respond to both hormonal and nutritional signals by 
changing their target gene´s expression. Common to their ligands is that they are all lipophilic and thus able to 
cross the cellular membranes. RARα, β and γ are NRs that mediate the effects of the metabolites of vitamin A on 
the gene expression. CREB, STAT and NF-κB are TFs that mediate the actions of hydrophilic compounds and 
proteins, such as Forskolin, epidermal growth factor (EGF) and tumor necrosis factor α (TNFα), respectively, 
through different cell surface receptors and signaling cascades. 
 
This study addresses the mechanisms of gene expression on the chromatin level by studying the expression of 
two different genes, human HAS2 and CYCLIN C, by different kinds of signaling routes aiming to characterize 
both the general properties and the individual differences. 
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2. Review of literature 
 
2.1 Gene regulation 
 
Every cell of a human individual contains the same genomic material, its genome, in the form of 2 x 22 plus 
either an XX or XY pair of sex chromosomes. A chromatin subregion being necessary to produce a functional 
unit of the cell, a protein, is called a gene. Genes are the hereditary units of a cell. They contain regulatory 
regions determining, under which conditions the protein is produced. Transcribed regions dictate the structure of 
the proteins and/or other functional sequence regions. In order to fulfill its tasks DNA is not acting alone in the 
cell, instead it is wrapped around a protein core, to form the basic unit of chromatin, the nucleosome. In this 
environment the genome interacts with a wide range of regulatory proteins. In addition, all cellular life can 
recognize and most likely responds to molecules in the extracellular environment. The responses of individual 
cells to those stimuli make a cell unique. The differences between our cells arise from the fact that not all of our 
genes are expressed in every cell and in every condition. Thus understanding how gene expression is regulated 
becomes extremely important in understanding the behavior of our cells. 
 
The regulation of gene expression involves a multitude of events leading finally to the beginning of gene 
transcription from a gene. The process consists of a series of spatially and temporally regulated events including 
several protein associations and dissociations in the regulatory regions of the genes. Gene expression is 
controlled mostly at the level of transcription initiation but also to a great extent on the chromatin level by 
controlling the activation status of chromatin. Below I will discuss in general and at the example of two genes, 
human HAS2 and human CYCLIN C, the regulatory regions, proteins involved and chromatin architecture. This 
should give an overview on the events responsible for the regulation of gene expression. 
 
2.1.1 The human genome 
The whole set of genetic material, which includes of the genes of an organism or a cell is known as its genome. 
The human genome was published in 2004 (International Human Genome Sequencing Consortium, 2004). Still, 
now in 2007 some of the genes are thought to be missing and the exact genomic structure is estimated to be 
correct for only 50 % of the predicted genes (Guigo et al., 2006). The human genome consists of 3.08 Gb of 
DNA of which only 1.2 % is coding for proteins. A large proportion (approximately 50 %) of the human genome 
consists of repetitive sequence and it is thought to have a less significant role. The remaining sequence contains 
the genes and the regions regulating gene expression. Humans have in total approximately 20,800 protein-coding 
genes, which can be classified according to their biological function. This labeling is the function of the Gene 
Ontology (GO) database. Nucleic acid binding proteins, TFs and other proteins maintaining and regulating the 
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genetic information form the largest group consisting of approximately 13.5 % of all genes. The second largest 
group, 12.2 % of all genes, consists the proteins responsible for signal transduction including signaling 
molecules, receptors, kinases and other regulatory molecules. Surprisingly, there are a large number of genes 
responsible for regulation of gene expression, which emphasizes the importance of understanding its 
mechanisms. Another argument supporting the importance of getting more information on the details of gene 
regulation comes from the comparison of human genome with the genomes of other species. On the level of 
genes and proteins humans are very similar to other mammals. For example, the genome-wide divergence of the 
human and chimpanzee is only 1.06 % (Chimpanzee Sequencing and Analyzing Consortium, 2005). Even 
though the differences at genomic level are very small, the differences at phenotype level become apparent. The 
variation is due to develop as a sum of small changes. It can be assumed that the gene regulation part has here a 
huge impact. 
 
2.1.2 Chromatin  
The eukaryotic genomic DNA is orderly packed in the nucleus (Horn, 2002). Nucleosomes form the basic unit of 
the packing. Each nucleosome consists of 147 bp of DNA wrapped around the protein core (consisting of an 
octamer of histones). The nucleosomes are separated from each other usually by 10 to 60 bp of so-called linker-
DNA. This structure forms the classical “beads-on-a-string” structure of DNA packing. Furthermore, 
nucleosomes are often packed into a 30 nm fiber, which can become even more compact by fiber-fiber 
interactions. In general, the density of chromatin packing affects its transcriptional activity. The more densely 
packed the chromatin is, the less transcriptional active it is. This is because chromatin condensation leads to a 
highly ordered chromatin structure that presents a physical obstacle for gene transcription by limiting the access 
of TFs and the Pol II core machinery to the target promoter DNA. The accessible open chromatin is called 
euchromatin and inaccessible, densely packed, chromatin is named heterochromatin. 
 
Nucleosome protein cores consist of eight subunits, called histones (two each of H2A, H2B, H3 and H4) 
(Kornberg and Thomas, 1974). As early as mid 1960s, histones were shown to be post-translationally modified 
in multiple ways (Allfrey et al., 1964). Those modifications are now known to strongly affect the chromatin 
activation status of the nucleosomes. Covalent modifiers of histones include enzymes that catalyze the 
acetylation (HATs), deacetylation (HDACs), methylation (HMTs), phosphorylation (histone kinases) and 
ubiquitination (Cheung et al., 2000; Grunstein, 1997; Turner 2002; Zhang and Reinberg, 2001). Histone 
modifications can either recruit (Bannister et al., 2001; Lachner et al., 2001; Zeng and Zhou, 2002) or exclude 
(Zegerman et al., 2002, Carmen et al., 2002; Nishioka et al., 2002) additional factors affecting chromatin 
structure and function. Specific modifications have been shown to correlate with specific transcriptional states 
forming a so-called histone code. For example, hypoacetylation of histones and trimethylation at lysine 9 (K9) of 
histone 3 are linked to condensed and transcriptionally inactive heterochromatin (Nakayama et al., 2001; 
Jenuwein et al., 2001). The trimethylation at K9 of histone 3 acts as a binding site for the heterochromatin-
associated protein-1, which causes formation and propagation of heterochromatin. Additionally, sumoylation of 
H4 can also recruit heterochromatin-associated protein 1 (Shioo and Eisenmann, 2003). General hyperacetylation 
of histones and methylation at K4 of histone 3 are linked to accessible and transcriptionally more active 
euchromatin (Schubeler et al., 2004). Even though there are some general features of active and inactive 
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chromatin, there are also exceptions. Kurdistani and co-workers published in 2004 microarray results showing 
that depending on the acetylated residue, the level of acetylation may correlate with gene expression either 
positively, negatively or not at all (Kurdistani et al., 2004).  
 
2.1.3 Regulation of gene expression 
The importance of understanding the mechanisms of gene regulation at the molecular level has become even 
more evident during the last few years. The major mechanism for regulating gene expression is to control the 
transcription (Kleinjan and van Heyningen, 2005). Transcription of a eukaryotic gene precedes by multiple 
events including decondensation of the locus, nucleosome remodeling, histone modifications, binding of 
transcriptional activators and CoAs to enhancers and promoters and finally, recruitment of the basal 
transcriptional machinery to the core promoter (Smale and Kadonaga, 2003). A vast majority of protein-coding 
genes are organized into multiple exons, which are then spliced into mRNA that is then translated into protein. 
The exon splicing is preceeded by transcription through the whole gene containing area from the transcription 
start site (TSS) to the transcription termination site. The minimal or core promoter containing the 5’ promoter 
element, contiguous with the TSS, is required to assemble the protein complex necessary for transcription 
(Levine and Tjian, 2003). A host of proteins necessary to transcription initiation are assembled into the Pol II, the 
general TFs, CoAs, CoRs, chromatin remodelers, HATs, HDACs, kinases and HMTs (Malik and Roeder, 2000; 
Näär et al., 2001; Näär et al., 1998; Jones and Kadanaga, 2000, Jenuwein and Allis, 2001). All eukaryotic cells 
express these proteins contributing to the initiation of every Pol II primary transcript. The total number of co-
regulators and proteins of the transcriptional machinery is between 200 and 300. 
 
2.1.3.1 TFs 
TFs are the proteins that regulate the choice of gene specific initiation sites of transcription. There are 2,000 to 
3,000 TFs in mammals (Brivanlou and Darnell, 2002). Two domains characterize them: a DNA-binding domain 
(DBD) that binds gene-specific regulatory sites and another domain possessing transcriptional activation 
potential, the transactivation domain. These two activities can also be divided between two partner proteins, one 
possessing the DNA-binding activity and the other the transactivation potential. 
 
The action of the most TFs involves firstly a cascade of transcriptional controllers of TF genes and secondly 
signals from outside that activate the TFs. The complete set of these regulatory events and the number of TFs are 
unique for each gene.  
 
Classification of DNA binding TFs 
The classification of TFs presented here is mainly based on the review from Brivanlou and Darnell (2002). TFs 
can be divided into positively and negatively acting factors. Binding of a positively acting TF to the regulatory 
region of its target gene induces the initiation of target gene transcription. Negatively acting TFs repress the gene 
transcription. The positively acting TFs can be divided into several classes (Fig. 1). First, they can be 
constitutively active or regulatory. The constitutively active TFs are discussed below. The regulatory TFs are 
either developmental (cell-specific) or signal-dependent. 
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Developmental or cell-specific TFs accumulate in specific cells during their development. The accumulation is 
regulated by sequential waves of regulated transcription of genes encoding these TFs (Driever and Nüsslein-
Volhard, 1989; Xanthopoulos et al., 1989; Johnston and Nüsslein-Volhard, 1992). These proteins enter the 
nucleus automatically upon being made and contribute directly to transcription. This group includes a series of 
helix-loop-helix factors (MyoD, Myf5 and myogenin) appearing in sequence in the control of muscle 
differentiation (Yun and Wold, 1996) and a series of factors required for β cell differentiation in pancreatic 
islands (Duncan et al., 1998). However, developmental TFs are not strictly cell-, tissue- or region-specific. 
 
The expression of signal-dependent TFs may be either developmentally restricted or they can be present in most 
or even all cells, but are inactive until cells are exposed to appropriate intra- or extracellular signals (Brivanlou 
and Darnell, 2002). Signal-dependent TFs can further be divided into the NR superfamily (discussed in more 
detailed in section 2.1.4), TFs activated by internal signals and those activated by cell surface receptor-ligand 
interactions. 
 
TFs that are regulated by internal signals form the most recently recognized group. The proteins of this group are 
activated by a variety of signals. Internal sterol concentrations regulate the proteolysis of a precursor to release 
sterol RE binding protein (Brown and Goldstein, 1999). Internally generated lipid compounds activate steroid-
like receptors (Forman et al., 1995; Kliewer et al., 1995). Also genome damage that demands DNA repair 
enzyme function and thus increases p53 concentration is an example of internal signal activating TFs (Levine, 
1997). 
 
TFs that are activated by cell surface receptor-ligand interactions can be further divided into constitutive nuclear 
factors activated by serine phosphorylation and into latent cytoplasmic factors (Brivanlou and Darnell, 2002). 
For example, liganded G protein-coupled cell surface receptor proteins and receptor tyrosine kinases (RTKs) 
regulate transcription through a multitude of serine kinase cascades that finally phosphorylate serine of the 
abundant resident nuclear factors. The substrate proteins include the Ets family, the c-Jun/c-Fos/ATM family and 
the CREB family (discussed in more detailed in section 2.3.1.1). 
 
Latent cytoplasmic factors reside in an inactive form in the cytoplasm until they get activated by proteins, which 
bind to cell surface receptors. These factors can get activated directly after receptor-ligand interaction by 
association of the TF with the activated receptor and following receptor phosphorylation. The factors can also 
undergo a more tortuous route of activation involving cytoplasmic serine phosphorylations and either promotion 
or inhibition of proteosomal proteolysis. Also Ca2+ or phosphoinosite fluctuations can cause TFs to release and 
move to the nucleus. Examples of latent TFs include STATs (discussed more detailed in section 2.3.2.1.1), the 
Rel/NF-κB family (discussed more detailed in section 2.3.3.1), the Wnt proteins (Hoppler and Kavanagh, 2007) 
and Notch (Weinmaster 2000). 
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Fig. 1. Classification of DNA binding TFs (according to Darnell and Brivanlou, 2002). Positive acting TFs can be divided 
into constitutive active TFs and regulatory TFs. Regulatory TFs are either developmental of signal dependent. Signal 
dependent TFs form three distinct groups: NR superfamily of TFs, TFs activated by internal signals and those activated by 
cell surface receptor-ligand interactions. The latter group of TFs falls into two distinct groups: resident nuclear factors and 
latent cytoplasmic factors. The TFs studied in this thesis are marked in bold. 
 
2.1.3.2 Regulatory DNA sequence elements 
A prerequisite for the regulation of gene expression is first activation of and then binding of DNA-binding TFs to 
the regulatory regions of a gene (Levine and Tjian, 2003). In order to get a complete understanding of the 
regulation of gene expression, not only TFs, chromatin modifiers and co-regulators but also the putative 
regulatory elements, on which they act must be found out. The regulatory regions of genes contain sequence-
specific binding sites for TFs. In general, a binding site or a RE is a short DNA sequence, usually 5 to 15 bp in 
length. The ability of a TF to bind certain DNA sequence is mainly determined by the structure of its DBD. 
However, the sequence of certain RE is not always very strict. A TF can bind REs that vary in their sequence by 
some nucleotides. However, some of the nucleotides are more critical than the others for the binding. Lack of a 
critical nucleotide in the RE sequence makes the binding of a TF impossible. 
 
Array-based assays and gelshift assays can be used to screen the ability of TFs to bind certain DNA sequences. 
However, the in vitro data they provide is not always corresponding to the situation in vivo. The progress in the 
field of bioinformatics has offered us ways to predict transcriptional regulatory mechanisms from sequence, gene 
expression and binding data (Siggia, 2005; Tavazoie et al., 1999; Birnbaum et al., 2001; Bussemaker et al., 
2001; Segal et al., 2003; Gao et al., 2004; Haverty et al., 2004; Ho Sui et al., 2005; Beer and Tavazoie, 2004). In 
spite of the great advance in this field during the previous years, bioinformatics still has its limitations in 
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identifying the regulatory regions and the regulators involved in the process giving the traditional methods still a 
big role in finding out the regulatory mechanisms. 
 
Simple eukaryotic regulatory regions 
As the number of genes between unicellular and metazoan eukaryotes is not too much different, the differences 
are supposed to arise from the regulation of gene expression. The regulation in eukaryotic genes derived from 
organism with multicellular bodies in general is far more complicated, as are also their eukaryotic regulatory 
regions. The regulatory unit of a gene from a unicellular eukaryote is simpler (Fig. 2) and the complexity of 
multi-protein transcription complexes that regulate gene expression has increased as a result of the need to 
coordinate and communicate information between different cells in a single body as well as dedicating specific 
functions to discrete cell populations known as organs. A simple eukaryotic gene promoter usually contains a 
TATA box that serves as a binding site for TATA-binding protein (TBP) (Struhl et al., 1998). Binding of TBP to 
the TATA box is generally enough for transcription initiation. The gene regulation in prokaryotes is largely 
dependent on the regulation of the binding of TBP. This depends on upstream activating sequences composing of 
two or three closely situated binding sites for one or two sequence-specific TFs (de Bruin et al., 2001). The 
majority of genes from simple eukaryotic organisms such as yeast contain just one upstream activating sequence 
located within a few hundred base pairs of the TATA box.  
 
Regulatory regions from metazoan eukaryotes 
Genes from these organisms are composed of highly structured regulatory DNAs directing complex gene 
expression patterns in many different cell types (Levine and Tjian, 2003). The core eukaryotic promoter consists 
of approximately 75 bp surrounding the TSS. In addition to the TATA box, also initiator element and the 
downstream promoter element can recruit the TBP containing the TFIID initiation complex (Smale and 
Kadonaga, 2003). Many genes contain binding sites for proximal regulatory factors located just 5’ of the core 
promoter. These factors, including GC-box binding specificity protein 1 (Sp1), rather than acting as classical 
activators or repressors, might serve as tethering elements recruiting distal enhancers to the core promoter (Su et 
al., 1991). The core promoter is usually not enough to fully recapitulate a complex eukaryote gene´s 
transcription. These genes contain other regulatory elements, enhancers, silencers and insulators that are 
scattered over distances of roughly 100 Kb, on average, in mammals. A typical eukaryotic gene is likely to 
contain several enhancers that can be located both in 5’ and 3’ regulatory region, as well as in introns (Levine 
and Tjian, 2003). An enhancer is typically approximately 500 bp in length and contains about ten binding sites 
for at least three different sequence-specific TFs. Each enhancer is responsible for a subset of the total gene 
expression pattern usually mediating expression within a specific tissue or cell type. In addition, a single 
transcription unit can be regulated by multiple enhancers, as they can integrate different regulatory inputs, such 
as those produced by multiple signaling pathways. Different enhancers can work independently to direct 
composite patterns of gene expression when they are linked within a common cis-regulatory region. A cis-
regulatory element is an element regulating the expression of genes located on the same strand. An example of 
this is the expression of the seven stripes of even-skipped in the Drosophila embryo that is dependent on five 
separate enhancers acting in an autonomous fashion (Small et al., 1993; Fujioka et al., 1999).  
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Insulators were first identified at defined boundaries between open and condensed chromatin domains (West et 
al., 2002). They are usually 300 bp to 2 kB in length and they contain clustered binding sites for large zinc finger 
proteins, such as Su(Hw) and CCCTCC binding factor (Burgess-Beusse et al., 2002; Bell et al., 2001). Insulators 
are known to contain both enhancer blocking and heterochromatin barrier activities (West and Fraser, 2005). 
They selectively block the long-range integration of a distal enhancer with a proximal target promoter when, 
positioned between them. They can also protect a gene from silencing by acting as a barrier to prevent the spread 
of the repressive heterochromatin from and adjacent transcriptionally silenced gene neighbors (Schedl and 
Broach, 2003). 
 
In addition to enhancers and insulators also DNA regulatory elements, called silencers take part into gene 
regulation. Silencers are elements that contain binding sites for repressors and thus prevent Pol II to start 
transcription. 
 
Fig. 2. Gene regulatory regions from simple and complex eukaryotes (adopted from Levine and Tjian, 2003). The 
simple eukaryotic regulatory unit consists of TATA box and usually one UAS and sometimes a repressive silencer element 
(a). The regulatory unit from a metazoan eukaryote is much more complex. The core promoter may contain in addition to 
TATA box also initiator element (INR) and downstream promoter element (DPE). Metazoan eukaryotic genes may contain 
multiple enhancers and silencers. At the same time, proximal promoter elements serve as binding sites for constitutive nuclear 
factors.  
 
2.1.4 The NR superfamily 
NRs typically function as ligand-activated TFs that regulate the expression of target genes involved in 
metabolism, development and reproduction (McKenna et al., 1999). The human genome contains genes for 48 
members of this TF family. The superfamily contains the classic endocrine receptors that mediate actions of 
steroid hormones, thyroid hormones and the biologically active forms of the fat-soluble vitamins A and D and 
also so-called orphan NRs, whose ligands, target genes and physiological functions were initially unknown. 
Today natural ligands are known for about half of these orphan NRs and these are now referred to as adopted 
orphan NRs (Fig. 3). 
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All characterized NR ligands are lipophilic compounds and therefore capable of diffusing through cellular 
membranes. The classical endocrine members of the NR superfamily include the glucocorticoid (GR), 
mineralocorticoid (MR), estrogen (ER), androgen (AR), progesterone (PR), thyroid hormone (TR), retinoic acid 
(RAR) and vitamin D (VDR) receptor (Chawla et al., 2001). They bind to their ligands with high affinity and 
their dissociation constant (Kd) values vary from 0.01 nM to 10 nM. 
 
The group of adopted orphan NRs contains receptors for fatty acids (peroxisome proliferator-activated receptors 
(PPARs)), oxysterols (liver X receptors (LXRs)), bile acids (farnesoid X receptor (FXR)) and xenobiotics 
(pregnane X receptor (PXR), and constitutive androstane receptor (CAR)). The group now includes the retinoid 
orphan receptors, which are supposed to respond to stearic acid and cholesterol, hepatocyte nuclear factor (HNF) 
4 α and γ, which are receptors for palmitic acid and receptors for anti-estrogens, estrogen-related receptors 
(ERRs) (Carlberg, 2004). The heterodimerization partner of many NRs, the retinoid X receptor (RXR), belongs 
to this group as well. The natural ligand for RXR is 9-cis RA. The adopted orphan NRs bind their ligands with 
lower affinity and their Kd values vary from 1 μM to 10 μM (Chawla et al., 2001). 
 
The remaining members of the NR family, for which still no ligand has been identified, are called true orphan 
NRs. According to phylogenic analysis the first NRs seem to have been true orphans and a ligand has been 
adopted later in evolution (Carlberg, 2004). This suggests that some of orphan NRs have yet to acquire a ligand. 
Orphan NRs are important TFs being pharmaceutical drug targets because of their association with human 
diseases. For example, small heterodimeric partner (SHP) is associated with obesity and nerve growth factor-
induced clone B (NGFI-B) with schizophrenia. 
 
2.1.4.1 Structure of NRs 
The structure of NRs is extremely important in determining their functional properties. NRs share a common 
structural organization. The majority of them contain a variable amino (N)-terminal domain, a highly conserved 
DBD, a hinge region and a discrete ligand-binding domain (LBD) (Mangelsdorf et al., 1995). The N-terminal 
domain is the least conserved part of the receptor. Most NRs carry a ligand-independent transactivation function 
in this part of the receptor (Tenbaum and Baniahmad, 1997). It serves as one contact point for co-regulators and 
often contains residues that can be phosphorylated affecting the activity of the receptor. The central part of the 
receptor contains the DBD and a hinge region the latter of which permits flexibility whilst the former allows 
simultaneous receptor dimerization and DNA binding. The DBD consists of two highly conserved zinc finger 
structures that target the receptor to specific DNA sequences, the REs. The hinge region may in some cases 
contain a nuclear localization signal or it can participate in co-regulator interactions. The LBD is in the carboxy 
(C)-terminal part of a NR. It is conserved to a lesser extent among different NRs and interacts directly with a 
ligand. The LBD encompasses a dimerization interface and a ligand-dependent activation function or helix 12. 
Helix 12 is crucial in the transition between inactive and active states of the receptor. 
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Endocrine 
Receptors  
Adopted Orphan 
Receptors  Orphan Receptors 
Ligands: 
High-affinity, 
hormonal lipids   
Low-affinity, 
dietary lipids   Unknown 
 TR α, β  PPAR α, δ, γ  DAX 
 RAR α, β, γ  LXR α, β  SHP 
 VDR  FXR  RevErbA α, β 
 ER α, β  PXR  TR2 α, β 
 GR  CAR  TLX 
 MR    PNR 
 PR  ROR α, β, γ  COUP-TF α, β, γ 
 AR  RXR α, β, γ  NGFI-B α, β, γ 
   HNF-4 α, γ  SF1 
   ERR α, β, γ  LRH 
     GCNF 
 
Fig. 3. The NR superfamily (according to Carlberg, 2004). The 48 members of the human NR superfamily can be sorted 
into the three groups, endocrine receptors, adopted orphan receptors and orphan receptors. 
 
2.1.4.2 Principles of the NR function 
NRs act as TFs in the cell nucleus. They exert their effects via sequence-specific binding to the regulatory 
regions of their target genes. This occurs mainly by ligand-dependent mechanisms although ligand-independent 
regulation of transcription is known. NRs can activate or repress target genes by binding directly to REs or by 
binding to other classes of DNA-bound TFs (Glass and Rosenfeld, 2000). Certain NRs, such as GR, need to be 
complexed with their ligand to translocate into the nucleus and subsequently bind DNA (Hermanson et al., 
2002). Other receptors, such as VDR, the RARs and the TRs can bind to DNA in their unliganded state and 
associate with CoR complexes that actively repress transcription. For all NRs the role of the ligands in the 
transcriptional process is to modulate the receptor’s functionality (Tenbaum and Baniahmad, 1997). Ligand-
binding induces a conformational change to the LBD of the NR and causes an exchange of protein-protein 
interaction partners. Within the NR-LBD the most C-terminal helix, helix 12, acts as a molecular switch (Nettles 
and Greene, 2003). In the agonistic conformation, helix 12 forms one border of a hydrophobic CoA binding cleft, 
allowing recruitment of a LXXLL (L, leucine; X non standard amino acid) motif, which is present in many 
transcriptional co-factors. In the absence of ligands or in the presence of antagonists, helix 12 adopts another 
conformation that favours NR interaction with CoRs. 
 
2.1.4.1.1 NR DNA binding 
NRs bind selectively to DNA in the regulatory regions of their target genes. The DBD of all NRs contains two α-
helices perpendicular to each other with their hydrophobic faces towards the protein core (Shaffer and Gewirth, 
2002; Carlberg, 2004). One of these α-helices, the recognition helix, is located behind the first zinc finger and 
inserts directly into the major groove of a hexameric DNA sequence. This DNA sequence is referred to as the 
core binding motif. Since the recognition helix is highly conserved within the NR family, multiple NRs 
recognize closely related hexameric DNA motifs. Most NRs interact preferably with the consensus sequence 
RGKTCA (R = A or G, K = G or T). GR, PR, AR and MR, exceptionally, prefer the sequence RGAACA. 
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Most NRs bind to DNA either as a homodimer or as a heterodimer with RXR. Some of the NRs, such as the 
RORs, steroidogenic factor 1 (SF-1), liver receptor homologue (LRH), NGFIBs, RevErbA, Drosophila 
homologue of tail-less and photoreceptor-specific NR can bind to DNA as a monomer. The steroid receptors ER, 
GR, MR, PR and AR and the orphan receptors RXR, HNF4, ERRs, TR2, chicken ovalbumin upstream promoter 
(COUP) TF and germ cell nuclear factor (GCNF) form homodimers, while RARs, TRs, VDR, PPARs, LXR, 
FXR, PXR and CAR bind to DNA as heterodimers with RXR (Carlberg, 2004). 
 
The hexameric core binding motif bound by NRs can be organized in three different configurations: direct 
repeats (DRs), inverted repeats or everted repeats. The number of nucleotides between the motifs varies as well. 
As the number of different NR REs is clearly less than the number of different dimeric NR complexes, every RE 
type is used by more than one NR. The types of REs used by NRs are shown in Fig. 4.  
RGKTCA
Direct repeats (DRs):
RGKTCA
5’-motif                      3’-motif
NN
nn
NN
NN
n = 0 GCNF-GCNF
n = 1 RXR-RXR
COUP-COUP
HNF-4-HNF-4
PPAR-RXR
n = 2 RevErbA-RevErbA
TR2-TR2
n = 3 RXR-VDR
n = 4 RXR-TR
RXR-LXR
RXR-CAR
RXR-PXR
n = 5 RXR-RAR
RXR-NGFI-B
n
Inverted repeats (IRs):
1
ER-ER
FXR-RXR
ERR-ERR
RGAACA TGTTCY3
GR-GR
MR-MR
PR-PR
AR-AR
RGKTCA TGAMCY
  NN
Fig. 4. The types of REs used by NRs (according to Carlberg, 2004). The most preferred RE for each type of homo- or 
heterodimeric NR complex is shown. NN represents 5’ flanking sequences. 
 
2.1.4.1.2 Co-factors 
An essential prerequisite for the direct modulation of a gene by certain NR ligand is the location of the activated 
NR close to the basal transcriptional machinery. This happens by binding a RE and by interacting with other 
proteins involved in the gene transcription making a connection to the basal transcriptional machinery. In 
addition to the connection of NR with the basal transcriptional machinery, also the chromatin must be accessible 
for NR or any other TF and Pol II. Co-factor proteins are factors than enable the efficient gene transcription 
regulated by NRs. 
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2.1.4.3 Classification of NR ligands 
NR ligands can be divided into two main group, first agonists and second inverse agonists and antagonists. 
Agonist binding to NR stabilizes the receptor in an active conformation and promotes the association of the LBD 
with CoAs. In addition, agonists disable the interaction of the receptor with CoRs. For example, all-trans RA 
serves as an agonist for RAR and the natural ligand for VDR, 1α,25(OH)2D3, is an agonist for VDR. Inverse 
agonists and antagonists support the interaction of the receptor with CoRs and stabilize the receptor in an inactive 
conformation. Synthetic compounds, such as C-1 phenyl substituted retinoids (Klein et al., 1996) and ZK168281 
(Bury et al., 2000) function as antagonists for RAR and VDR, respectively. Inverse agonists for RAR include the 
synthetic compound AGN193013 (Klein et al., 1996) while the two-side chain 1α,25(OH)2D3 analog Gemini can 
act as an inverse agonist for VDR (Bury et al., 2000; Macias-Gonzalez et al., 2003). 
 
In the simple mode, NR agonists are thus compounds that when bound to the receptors activate them and trigger 
the response in the cell. Antagonist binding fails to activate the receptor and actually blocks the activation by 
agonists through competing with the same binding site. Many of NR ligands may work as agonists in one tissue 
but as antagonists in others (Weatherman et al., 1999). That makes the terms agonist and antagonist not a perfect 
way to describe the ligands utilized in NR signaling.  
 
2.1.4.4 RAR-mediated gene regulation  
The RAR sub-family of NRs mediates the actions of retinoids derived from dietary vitamin A and from the 
provitamin β-carotene of plant origin (Altucci and Gronemeyer, 2001). There are three subtypes of RAR (α, β 
and γ) that are encoded by different genes. In addition, each subtype expresses several isoforms that differ in 
their N-termini due to alternative mRNA splicing and different promoter use. RAR transduces the retinoid signal 
together with RXR (of which there are also three sub-types: α, β and γ) acting as RAR-RXR heterodimer 
(Kastner et al., 1997). Both all-trans RA and its 9-cis isomer activate RARs. RXRs are activated only by 9-cis 
RA. Binding of a ligand to RAR induces RAR-RXR heterodimer formation. RARs and RXRs alone bind poorly 
to DNA, but the effective DNA binding required for receptor function is achieved when a RAR-RXR 
heterodimer is formed. In the absence of agonists or in the presence of antagonists, RAR target genes are 
repressed, whereas agonistic ligand binding causes transcriptional activation. The basic regulatory mechanism of 
ligand activated RARs is further complicated by the interaction of CoAs and CoRs. Agonist binding causes a 
conformational change in the LBD of RAR that leads to replacement of CoRs with CoAs. CoAs interact with 
HATs leading to loosening of the chromatin. Further interactions with the mediator (MED) complex enable 
contact to the basal transcriptional machinery and subsequent gene transcription. Poly-ADP-ribose polymerase 1 
(PARP-1) has quite recently been shown to be important in RA-mediated gene expression (Pavri et al., 2005). 
Pavri and co-workers demonstrated that PARP-1 is a co-regulator of RAR-mediated gene expression acting in 
concert with the MED complex. It binds MED via its BRCT domain and this interaction is critical in determining 
whether the gene will be transcribed or not. In the absence of PARP-1 the RAR-MED-complex is unable to 
switch MED to its active form abrogating gene activation, while the presence of PARP-1 enables MED 
activation. 
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Retinoid regulation of the target gene transcription rate and the duration of the response are further complicated 
by covalent modifications of the retinoid receptors by phosphorylation triggering CoA association and 
ubiquitinylation involved in receptor degradation.  
 
2.1.4.4.1 RAREs 
RAR-RXR heterodimers modulate the frequency of transcription initiation of target genes by binding to RAREs 
in the promoter region of their target genes. The sequences bound by RAR-RXR heterodimers are rather 
pleiotropic (Glozak et al., 2003). Although there is a loose consensus sequence of two directly repeated 
RGKTCA half-sites separated by five nucleotides (DR5-type REs), the spacing, relative position and number of 
these repeats are highly variable. RARs have been shown to bind and activate transcription via half-sites 
separated by up to 150 nucleotides (Kato et al., 1995). RAR-RXR heterodimers also bind to DRs separated by 1 
(DR1-type REs) or 2 nucleotides (DR2-type REs). RXRs can bind to DR1-type REs as RXR-RXR homodimers. 
RAREs can be located also within distant control regions. In addition to their location close to the TSS of their 
target genes, RAREs have been identified in introns or kilobases downstream of genes (Glozak et al., 2003). 
There is also some evidence of the ability of DR2-type REs in repetitive Alu sequences to function as RAREs 
(Laperriere et al., 2007). 
 
2.1.4.4.2 RAR interference with other signaling pathways 
RARs are known to interfere with a wide variety of other signaling pathways making the understanding of 
retinoid signaling even more complicated (Pfahl and Chytil, 1996). Promoters of RAR target genes contain in 
addition to the cognate RAREs also some other TF binding sites. Therefore RARs can interact with other TFs 
either in a synergistic or an antagonistic way. For example, RARs co-operate with Sp1/Sp3 TFs in the 
transactivation of the CYP26 gene. Similarly, in the presence of cytokines, STAT5 co-operates with RARs to 
achieve maximum transcription of some RA responding genes (Si and Collins, 2002). Such synergistic effects 
are likely to result from the co-operative recruitment of co-regulators or increased chromatin remodelling 
(Bastien and Rochette-Egly, 2004). Retinoids are thus also able to antagonize the activation of genes by 
interfering with other TF signaling systems. The best-studied example of this action is the TF activator protein 1 
(AP-1), which is a heterodimer of the proteins Jun and Fos. AP-1 activates the genes of growth factors, 
inflammatory peptides, oncogenes and tumor promoters, which usually results in an increased cell proliferation. 
In the presence of their respective ligands, RARs as well as RXRs can block AP-1 activity and thus directly 
interfere with many cell proliferation signals. However, the mechanistic basis remains elusive. Several distinct 
mechanisms have been proposed. These include the competition for limiting amounts of CoAs, disruption of the 
Jun-Fos dimerization or exclusion of some components (e.g. kinases) from the AP-1 complex. Retinoids have 
also been shown to inhibit the phosphatidylinositol 3 kinase/Akt pathway (Bastien and Rochette-Egly, 2004; del 
Rincon et al., 2003) and to interfere with CREB signaling (Aggarwal, 2005). Retinoids activate CREB in a non-
genomic way, through activation of protein kinase C, ERK and RSK in the absence of the influence of RAR-
RXR heterodimers. 
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2.1.4.4.3 The role of RAR in normal physiology and disease 
The natural ligands for RARs, the retinoids can be both detrimental and beneficial. They are modulators of 
cellular proliferation and differentiation as well as effectors of morphogenic changes. The production of retinoids 
needs to be tightly controlled for proper organogenesis. All-trans RA regulates the expressions of homeo-box 
containing (HOX) genes specifying positional information during morphogenesis (Kessel and Gruss, 1991; 
Marshall et al., 1992; Marshall et al., 1994; Ogura and Evans, 1995) and several HOX genes, e.g. HOXB1, 
contain RAREs in the 5’ or 3’ region (Ogura and Evans, 1995). Lack of vitamin A is known cause severe 
malformations and too high concentrations are teratogenic. It has been shown that nearly all of the congenital 
malformations caused by vitamin A deficiency are due to the absence of RAR or RXR functions.  
 
The development of central nervous system is strongly influenced by RA, which is known to provide information 
for several processes during vertebrate development including positional information necessary for the proper 
functioning of the nervous system (Durston et al., 1989; Maden et al., 1991; Maden and Holner, 1992). Null 
mutations in retinoid receptors were subsequently shown to lead to abnormal neural development (Mendelssohn 
et al., 1994). At the molecular level the regulation happens most likely by regulation the HOX gene expression 
patterns (Kessel and Gruss, 1992; Ogura and Evans, 1995).  
 
RA also regulates the development of several other organs. The molecular mechanisms of many of these events 
are not established yet. RA appears to have a role in cardiac muscle morphogenesis as RAR null mutations 
combined with RXR mutation led to various defects often blocking the development (Lohnes et al., 1994; 
Mendelsohn et al., 1994). Similarly, RA is supposed to influence the development of pulmonary system (Chytil, 
1984). The expression of RAR and RXR in lung tissues is influenced by all-trans RA (Hag et al., 1991). 
Likewise, exogenous RA can induce the branching of the trachealveolar system. Again, several HOX genes 
influenced by RA have been identified in the lungs of newborns (Bogue et al., 1994). 
 
Retinoids have also an important role in adult physiology. Retinoids and their cognate receptors are required for 
the proper functioning of certain organs, such as the brain (de Urquiza et al., 2000; Krezel  
et al., 1998), liver (Imai et al., 2001; Wan et al., 2000), the reproductive system (Kastner et al., 1996) and the 
immune system, where they are involved both in cell-mediated and humoral immunity (Chun et al., 1992; 
Dennert and Lotan, 1978).  
 
Because of their importance in the control of normal physiology natural retinoids and a large number of synthetic 
retinoids are used in the treatment of medical conditions (reviewed in Soprano et al., 2004). All-trans RA, 13-cis 
RA and some synthetic retinoids are used in the therapy of several dermatoses (Peck and DiGiovanna, 1994). For 
example, acne vulgaris and photodamaged skin are often treated successfully by a topical application of 
retinoids. The medicine for acne, Adapalene, activates selectively RARβ and -γ (Bernand et al., 1992; Delescluse 
et al., 1991). Natural and synthetic retinoids have also shown promise for the prevention and treatment of 
cancers. The presence of retinoids can program cells to differentiate or even enter programmed cell death and can 
therefore interfere with tumorigenesis at several levels. Differentiation therapy has impressive beneficial effects, 
such as in the treatment of acute pro-myelocytic leukaemia, which is caused by genetic defects leading to 
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dysregulated RAR signaling. The origin of acute pro-myelocytic leukemia is a chromosomal translocation that 
fuses the pro-myelocytic leukemia gene PML and the RARα gene. PML-RARα has several effects including 
disturbance in the regulation of p53 (PML acts as a CoA for p53) (Guo et al., 2000). Also many other cancers are 
being treated with retinoid-based therapies, examples of these include Kaposi’s sarcoma, squamous-cell 
carcinoma and T-cell lymphoma. Retinoids can also be combined with other therapies. For example, retinoids 
and the anti-estrogen/estrogen antagonist tamoxifen are used together to treat breast cancer. 
 
Although retinoids have shown to be promising in the treatment of several conditions the broad clinical use of 
retinoids has been hindered by their undesired side effects ranging from mild skin rashes to severe nausea, bone 
fractures and embryonic malformations (reviewed in Pfahl and Chytil, 1996). Nowadays many synthetic 
retinoids are available for experimental exploitation. There are selective agonists and antagonists for every 
receptor subtype (for both RARs and RXRs). These synthetic retinoids have the advantage of having not as many 
side effects as the naturally occurring retinoids.  
 
2.1.4.5 VDR-mediated gene regulation 
The biologically most active metabolite of vitamin D, 1α,25(OH)2D3 mediates its effects by acting via its 
receptor VDR (Chatterjee et al., 2001; Sutton et al., 2003). 1α,25(OH)2D3 binds to VDR with high affinity (Kd = 
0.1 nM) inducing the formation of a VDR-RXR heterodimer. RXR was long thought to be a non-permissive or 
silent companion of VDR, but later on more evidence imply also RXR having an active role in 1α,25(OH)2D3-
mediated gene regulation (Bettoun, 2003). In its unliganded state VDR is associated to CoR proteins (Burke and 
Baniahmad, 2000) that link it to enzymes with HDAC activity leading to chromatin condensation (Polly et al., 
2000). Thus, the actions of VDR resemble those of RAR and TR. 1α,25(OH)2D3 binding to VDR causes a 
change in the conformation of its LBD resulting in the replacement of CoRs by CoAs (Leo and Chen, 2000). 
This then leads to interactions with HATs and to subsequent loosening of the chromatin. Like RAR, VDR then 
interacts with the MED complex that bridges it to the basal transcriptional machinery. 
 
2.1.4.5.1 VDREs 
VDR-RXR heterodimers need to bind to a VDRE in order to modulate transcription. VDR recognizes DNA 
sequences with the consensus RGKTSA (R = A or G, K = G or T, S = C or G). As RXR also contacts DNA, 
simple VDREs are often formed by a direct repeat of two hexameric core binding motifs spaced by 3 nucleotides 
(DR3-type VDRE) (Carlberg, 1996). VDR-RXR can also bind to two hexameric motifs arranged as a DR spaced 
by 4 nucleotides (DR4-type VDRE) (Quack and Carlberg, 2000) or as an everted repeat with nine intervening 
nucleotides (ER9-type VDRE) (Nayeri et al., 1995). Individual VDREs have been shown to be able to induce 
1α,25(OH)2D3-mediated transactivation on their own. The presence of multiple VDREs in a certain promoter 
suggests that they act synergistically. For example, a DR3-type VDRE at a core of a VDRE cluster on human 25-
hydroxyvitamin D3-24-hydroxylase (CYP24) gene promoter is the most potent human VDRE known so far (Chen 
and DeLuca, 1995). CYP24 is an enzyme that begins the degradation of 1α,25(OH)2D3 by hydroxylation it at 
carbon 24. 
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2.1.4.5.2 The role of VDR in normal physiology and in disease 
Vitamin D3 is taken up to the cells from diet or synthesized in skin with the help of UV light. Its bioactive 
metabolite, 1α,25(OH)2D3, is an endocrine hormone present everywhere in the body because of the circulation. 
Furthermore, the VDR is ubiquitously expressed enabling 1α,25(OH)2D3 to exert its effect throughout different 
tissues. 1α,25(OH)2D3 is predicted to have hundreds of responding genes. 
 
The best-characterized processes regulated by 1α,25(OH)2D3 are the regulation of mineral homeostasis and 
skeletal integrity. In mammals, the maintenance of bone integrity depends on the regulated absorption and 
distribution of bone forming mineral. VDR target genes are involved in the calcium and phosphorous intake via 
the intestine. These target genes involve intracellular transporter proteins calbindins D-9K and D-28K and the 
calcium pump PMCA (Bouillon et al., 2003). The increase in the activity of these genes increases the intake of 
minerals. VDR has also target genes involved in bone remodeling. Bone resorbing osteoclasts lack VDR mRNA, 
but the bone-forming osteoblasts express the VDR. Osteoblasts express known 1α,25(OH)2D3-responsive genes, 
such as osteocalcin, which is associated with the mineralized matrix of bone and enables osteoclast adhesion, 
acts as a component of elastic fibers in skin and aorta and also modulates immune reactions (Reinholt et al., 
1990; Baccarani-Contri et al., 1995; Weber et al., 1996). 
 
VDR has been shown to have important roles in the control of cell growth and differentiation, both in normal and 
malignant tissues. Already in 1981, 1α,25(OH)2D3 was shown to arrest the proliferation of murine myeloid 
leukemia cells and induce their differentiation into macrophages (Abe et al., 1981). Since then research 
concerning on the role of VDR in various cancer models and the modulation of cellular differentiation has 
emerged.  
 
Many genes responsible for the regulation of cell cycle have been shown to be VDR target genes making it 
obvious that the anti-proliferative effects of 1α,25(OH)2D3 are mediated by those genes. As discussed in section 
2.2.2, the progression of the cell cycle is controlled by cyclin-dependent kinases (CDKs) and cyclin complexes. 
The initiation phase is tightly controlled by CDK4/6 complex that binds cyclin D. This complex when activated 
phosphorylates and thus inactivates the retinoblastoma protein (Rb). This leads to TF E2F release from its 
inhibitor Rb and initiates the transcription of genes needed for the progression into the S phase (Harbour and 
Dean, 2000). The activity of CDK4/6 complex is inhibited by the specific INK4 family of CDK inhibitors 
including the proteins p16INK4A (Kamb et al., 1994; Serrano et al., 1993), p15INK4B (Hannon and Beach, 1994), 
p18INK4C (Guan et al., 1994) and p19INK4D (Chan et al., 1995). CDK complexes are also inhibited by other CDK 
inhibitors, such as p21CIP1/WAF1 (Harper et al., 1993; El-Deiry et al., 1993) p27KIP1 (Toyoshima and Hunter, 1994) 
and p57KIP2 (Lee et al., 1995; Matsuoka et al., 1995), which belong to the family of CIP/KIP CDK inhibitors. 
Both, p21CIP1/WAF1 and p27KIP1genes have been shown to be upregulated by 1α,25(OH)2D3 (Liu et al., 1996; 
Wang et al., 1996). The 1α,25(OH)2D3 response of the p21 gene is mediated by VDR together with another TF, 
p53 involved in cell cycle regulation (Saramäki et al., 2006). In addition to p21CIP1/WAF1 and p27KIP1, also many 
other CDK inhibitors, cyclins and CDKs are under VDR regulation (Jensen et al., 2001). 
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VDR is also known to regulate both proto-oncogenes and tumor suppression genes. A proto-oncogene, c-fos and 
a tumor suppressor, E-cadherin have both been reported to be under the control of 1α,25(OH)2D3 (Mathiasen et 
al., 1993; Pálmer et al., 2001). VDR affects also growth factor signaling, such as transforming growth factor 
(TGF) β (Wu et al., 1999; Pálmer et al., 2003) and insulin-like growth factor (IGF)-1 (Peng et al., 2004; 
Drivdahl et al., 1995) signaling. 
 
VDR is involved in the regulation of immune responses. It has been reported to have immunosuppressive action 
leading to suppression of inflammatory cytokines most likely because of VDR/AP-1 interaction (Alroy et al., 
1995). VDR can also block the interaction of the TFs Fos, Jun and nuclear factor of activated T-cells (NF-AT) 
(Towers et al., 1999). Because of the immunosuppressive nature of VDR ligands, they have been used 
beneficially in several autoimmune diseases, such as multiple sclerosis (D’Ambrosio et al., 1998), rheumatoid 
arthritis (Andjelkovic et al., 1999) inflammatory bowel disease and type I diabetes (Gregori et al., 2002; 
Cantorna et al., 1998). VDR can also interfere with prostaglandin synthesis by totally blocking IL-1β-stimulated 
prostaglandin E2 (Tetlow et al., 1999), as well as it affects antigen-presenting cells. In mouse experiments, 
vitamin D could inhibit dendritic cell differentiation (Griffin et al., 2001). Due to its effects on antigen-
presenting cells, 1α,25(OH)2D3 and its analogs are used in graft rejection therapies. In addition, 1α,25(OH)2D3  
treatment has been shown to induce tolerogenic dendritic cells, which protects against allograft rejection (Adorini 
et al., 2003). 
 
2.1.5 Signaling via cell surface receptors 
In contrast to lipophilic NR ligands, there are numerous hydrophilic signaling compounds that cannot pass 
membranes and need to exert their effects via their cell surface receptors. These signaling molecules include 
peptide hormones, neuropeptides, neurohormones as well as growth factors (Brivanlou and Darnell, 2002). Their 
binding to a receptor on the surface of the cell thus initiates a chain of intracellular reactions, a so-called signal 
transduction cascade, finally leading to nucleus resulting in changes in gene expression. 
 
Cell surface receptors include guanosine nucleotide binding protein (G protein)-coupled receptors, RTKs, 
cytokine receptors, nonreceptor protein-tyrosine kinases and several other receptors linked to other enzymatic 
activities.  
 
2.1.5.1 G protein-coupled receptors 
G protein-coupled receptors form the largest group of cell surface receptors that transmit signals to intracellular 
targets via the intermediary action of G proteins. The genes for those receptors account for approximately 5 % of 
the genes in human genome (Morris and Malbon, 1999). The ligands are chemically diverse including 
neurotransmitters, hormones, phospholipids, odorants and photons (Gavi et al., 2006). The receptors are 
characterized by seven transmembrane α-helices. Ligand binding to the extracellular domain of these receptors 
induces a conformational change that allows the cytosolic domain of the receptor to bind a G protein that 
associates at the inner surface of the plasma membrane. Receptor-G protein interaction activates the G protein 
which then dissociates from the receptor and carries the signal to an intracellular target, which is often an enzyme 
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or an ion channel. One important G protein target is adenylyl cyclase, an enzyme making the important second 
messenger cyclic AMP (cAMP).  
 
Forskolin 
Forskolin is a diterpene that is produced by the Indian and East African Coleus plant, Plectranthus barbatus. It is 
now in extensive use in clinical studies and also in treatments of several conditions. Forskolin resensitizes cell 
receptors by activating the enzyme adenylyl cyclase and thus increasing the cAMP levels in the cell. This effect 
accounts for its versatile role in the body. Forskolin works as a vasodilator (Bubolz et al., 2005). In addition, it 
has been studied extensively as a weight loss aid. Godard and co-workers showed that in a clinical study 
Forskolin significantly increased lean mass, bone mass and also testosterone levels (Godard et al., 2005). 
Forskolin can also be used to treat glaucoma, reduce urinary tract infections and enhance the ability of antibiotics 
to kill bacteria that would normally survive. It increases skin’s natural resistance to burning under UV light and 
stimulates tanning response when applied topically. It is also used to promote nerve repair by increasing cAMP 
concentrations. It has shown to be able to activate the proliferation of Schwan cells. In addition, various 
experimental studies are underway in using Forskolin as an adjunct treatment for diseases such as Parkinson’s or 
nerve damage caused by trauma or accident.  
 
2.1.5.1.1 CREB 
cAMP-response element-binding protein 1 (CREB1) is an important TF implicated in a large number of 
biological processes, including long-term neuronal plasticity, cell survival, circadian rhythms, adaptation to 
drugs and hormonal regulation of metabolism (Lonze and Ginty, 2002). To get activated, CREB1 needs to be 
phosphorylated. This is done by protein kinase A (PKA) and by a variety of other kinases, such as 
calcium/calmodulin-dependent protein kinases, SNF1-like kinase and ribosomal S6 kinase 1, at the same critical 
serine residue, Ser-133. The phosphorylation is essential for the recruitment of the transcriptional CoA, CREB-
binding protein (CBP) or its paralog p300 (Chrivia et al., 1993). CBP induces transcription via its acetylase 
activities and by interacting with the core transcriptional machinery (Vo and Goodman, 2001). Recently, it has 
been noticed that other phosphoserine-133-independent mechanisms are required for full activation of CREB 
(Johannessen and Moens, 2007). These include multiple phosphorylations by a diversity of kinases on other 
phosphoacceptor sites in CREB1. 
 
The CREB-CBP pathway includes first the binding of CREB to the CRE in target genes following the 
recruitment of the CoA CBP (Cha-Molstad et al., 2004) (Fig. 5). The first CRE (TGACGTCA) was identified in 
the promoter of somatostatin gene (Gonzalez et al., 1989). Nowadays it is predicted that there may be as many as 
10,000 CREB-binding sites in the mammalian genome (Euskirchen et al., 2004). The binding has also been 
demonstrated to be cell type specific (Cha-Molstad et al., 2004). Cell type specificity might be due to the fact 
that epigenetic differences in chromatin from one cell type to another determine the population of genes capable 
of binding CREB and, in turn, the pattern of gene responses to the wide variety of pathways that activate CREB1 
function. CREB1 binding to CRE is supposed to be constitutive, not regulated and CREs in most genes are 
occupied by CREB under basal conditions. (Hagiwara et al., 1993; Richards et al., 1996; Gonzalez and 
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Montminy, 1989). Thus, the regulation of CREB-CBP pathway happens mainly via regulating the recruitment of 
CBP. 
 
 
Fig. 5. Overview of CREB signaling (www.biocarta.com). The main feature of CREB signaling is phosphorylation of 
CREB and binding to CRE to induce target gene transcription. 
 
2.1.5.2 Receptor tyrosine kinases 
The receptors for most growth factors belong to the group of RTKs (Pawson and Scott, 1997). Examples of 
RTKs include the cell surface receptors for insulin, IGF receptor 1 and epidermal growth factor (EGFR) (Gavi et 
al., 2006). These receptors are directly linked to intracellular enzymes, which phosphorylate their substrate 
proteins on tyrosine residues. Ligand-binding first induces receptor dimerization leading to autophosphorylation 
of the receptor. The auto-phosphorylation in the catalytic domain plays a regulatory role by increasing the 
receptor protein kinase activity. The phosphorylation outside of the catalytic domain creates specific binding 
sites for additional protein that transmit intracellular signals downstream of the activated proteins. The best 
characterized of these downstream signaling molecules are Src homology 2 (SH2) domain containing proteins. 
 
2.1.5.2.1 EGF 
EGF is an important growth factor regulating cell growth, proliferation and differentiation. There is a family of 
mammalian polypeptide growth factors that exhibit significant sequence identity with EGF (Holbro and Hynes, 
2004). All these EGF-related peptide growth factors are encoded by distinct genes and contain an EGF-like 
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domain that confers binding specificity. They are responsible for activating the four different EGFRs, also called 
ErbB receptors. The group of EGF-related growth factors includes in addition to EGF, TGF-α, amphiregulin, 
betacellulin, heparin-binding EGF, epiregulin and neuregulins 1-4. All the peptides of this group are synthesized 
as glycosylated integral membrane precursor proteins with extracellular domains containing an EGF-like mature 
peptide sequence. The precursor of EGF contains approximately 1200 amino acid residues. The sequence of this 
precursor includes in addition to the sequence of EGF, eight EGF-like units and, near the C-terminus, a 
hydrophobic sequence that is characteristic of an integral membrane protein. The membrane-associated precursor 
of EGF is biologically active (Dobashi and Stern, 1991) as is the mature, soluble peptide that is released from the 
extracellular domain by proteolytic cleavage (Pandiella et al., 1992). 
 
EGF signaling 
EGF and all the EGF-related peptides act via binding to the cell surface membrane receptor, EGFR. EGFR 
belongs to the group of RTKs, which are the primary mediators of the signals regulating complex biological 
processes, such as cell growth, differentiation, motility and death (Hackel et al., 1999) (Fig. 6). EGF binding to 
EGFR induces the formation of a dimer and, as a consequence, the intrinsic kinase domain of the receptor is 
activated. This results in autophosphorylation at multiple tyrosine residues within the cytoplasmic tail of the 
protein (Holbro and Hynes, 2004). These phosphorylated residues serve then as docking sites for a variety of 
signaling molecules, whose recruitment leads to the activation of many downstream signaling pathways. Among 
the most strongly activated and best-studied signaling cascades, that EGFR initiates from the plasma membrane, 
are those that go through RAS, phospholipase Cγ (PLC-γ) and STAT proteins (Wells and Marti, 2002). 
 
Proteins with SH2 domains and PTB domains binding to EGFR start the signaling cascade going via the RAS 
pathway. After binding to EGFR SH2-containing and growth factor receptor-bound protein 2 adaptor proteins 
attract the GTP-exchange factor son-of-sevenless. This activates RAS (Lowenstein et al., 1992) and in turn RAS 
activates other small GTPases (Cdc42, Rho and Rac), which have a critical role in the control the cytoskeleton. 
RAS also initiates a kinase cascade activating the extracellular PLC-γ signal-regulated kinases 1 and 2 (ERK1 
and 2) and the mitogen-activate protein kinase (MAPK) pathway through Raf and MAPK/ERK kinase (MEK). 
ERK can then activate the intracellular-limited protease calpain II or it can translocate to the nucleus and act as a 
TF (Wells and Marti, 2002). 
 
PLC-γ is one of the best-characterized substrates of the EGFR. PLC-γ binds to phosphotyrosines of EGFR to 
align itself for cross-phosphorylation and activation. It hydrolyses phosphoinosite 4,5-bisphosphate to produce 
inositol trisphosphate and diacylglycerol (Wells and Marti, 2002). Inositol trisphosphate acts as a second 
messenger molecule and liberates stored calcium from the endoplasmatic reticulum and thereby activates 
calcium-dependent enzymes and processes. Diacylglycerol is an activator of protein kinase C (PKC). PKC plays 
important roles in regulating several processes involved in cell growth and differentiation.  
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Fig. 6. Overview of EGF signaling (www.sigma-aldrich.com). The different pathways of EGF signaling starting from the 
binding of EGF to its receptor and leading to transcription of target genes.  
 
2.1.5.2.1.1 STAT 
STATs are a family of latent cytoplasmic proteins that acts as TFs (Benekli et al., 2003) and participate in many 
signaling systems. STAT target genes influence growth, survival, apoptosis, host defence, stress and 
differentiation functions, depending on the signaling pathway and the target tissue (Levy and Darnell, 2002). In 
total seven STAT genes have been identified in mammals in three chromosomal clusters (Benekli et al., 2003). 
 
More than 35 different polypeptide ligands are known to activate one or more different STATs. Thus STATs are 
involved in a wide range of biologic events (Darnell, 1997). Three of the known STATs have a narrow activation 
profile: STAT2 is activated only by interferon α; in lymphocytes STAT4 is activated only by interleukin 12 (IL-
12) and interferon α; and STAT6 is activated only by IL-4 and IL-13. In contrast, STATs 1, 3, 5A and 5B are 
activated by many different ligands. STAT activation involves cytoplasmic recruitment to activated cell-surface 
receptors, tyrosine phosphorylation, receptor release, dimerization and nuclear translocation followed by site-
specific DNA binding to control target gene expression (Murray, 2007). STATs are the only known TFs that 
become activated from a latent state by tyrosine residue phosphorylation (Brivanlou and Darnell, 2002). Ligands 
that can induce STAT activation can be associated with Janus kinases that tyrosine-phosphorylate the liganded 
receptor and then the associated STAT. STATs can also be activated by RTKs, such as EGFR, by non-RTKs, 
such as Src and Abl, and through G protein-coupled cell surface receptors (Bromberg and Darnell, 2000). There 
is not much known about the specificity of STAT activation. For example, EGF is known to induce the activation 
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of STAT1, STAT3 and STAT5 (Zhang et al., 2003). However, the activation is different in different cell types. 
STAT3 has been demonstrated to play critical roles in EGF signaling in normal and malignant cells.  
 
Once STATs are phosphorylated, they form dimers through reciprocal SH2-phosphotyrosine interaction. They 
form either homo- or heterodimers depending on intermolecular SH2-phosphotyrosine interactions (Darnell, 
1997) and enter the nucleus. The mechanism of the nuclear entry of the tyrosine-phosphorylated dimers is not 
exactly known, but it has been suggested to happen through binding of the dimer to an importin (Sekimoto et al., 
1997). Nuclear entry is then followed by specific DNA binding and participation in the control of gene 
expression. STAT dimers with a two-fold symmetry bind in the nucleus to a palindromic DNA motif (Darnell, 
1997). This palindromic core motif, TTCN2-4GAA, is recognized by all the different STATs (Ehret et al., 2001). 
Activation of STAT target genes requires CoA recruitment by STAT transactivation domains and interaction 
with acetyltransferases, minichromosome maintenance proteins and additional factors (Levy and Darnell, 2002). 
 
2.1.5.2 Cytokine receptors and non-RTKs 
Cytokine receptors do not posses any intrinsic enzymatic activity but they act by stimulating intracellular 
protein-tyrosine kinases with which they are non-covalently associated. Ligand binding to receptor induces 
dimerization of the receptor and activates the non-RTKs. The activated kinases then phosphorylate the receptor 
that can then recruit downstream signaling molecules containing SH2 domains. Cytokine receptor/non-RTK 
combination can thus work analogously to the RTKs, The family of cytokine receptors contains the receptors for 
most cytokines and also receptors for some polypeptide hormones (e.g., the growth hormone receptor). Non-
RTKs are made of nine distinct families including Src, Jak, Abl, Fak, Fps, Csk, Syk, Pyk2, Btk (Gavi et al., 
2006). 
 
2.1.5.2.1 NF-κB 
NF-κB is a TF involved in the control of a large number of normal cellular and organ level processes, such as 
immune and inflammatory responses, development, cellular growth and apoptosis. In addition, it is persistently 
active in a number of disease states, including cancer, arthritis, chronic inflammation, asthma, neurodegenerative 
diseases and heart disease (Kumar et al., 2004). It belongs to the family of Rel proteins of which the most 
common member is a heterodimer consisting of p50 and p65 proteins (Schmitz and Baeuerle, 1995). The activity 
of NF-κB is regulated by inhibitory IκB proteins (Beg and Baldwin, 1993) (Fig.7). In most cells, NF-κB is 
present as a latent, inactive IκB-bound complex in the cytoplasm. IκB masks the nuclear localization signal in 
NF-κB preventing it entering to the nucleus. In response to external stimulus IκB gets phosphorylated by specific 
kinases, called IκB kinases (IKK). Phosphorylation leads to degradation of IκB following NF-κB translocation to 
the nucleus, DNA binding and contacts with MED and CoA proteins. NF-κB can be activated by a wide variety 
of signals including bacterial and viral antigens, UV irradiation, free radicals and several cytokines including in 
total nine different ILs and both TNF α and β. The consensus sequence for NF-κB DNA binding is 
GGGRNNYYCC, (Y = C or T, N = any base). 
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Fig. 7. Different pathways of NF-κB signaling (www.biocarta.com). The different pathways leading to degradation of IκB 
and activation of p50/p65 heterodimer are depicted.  
 
2.1.5.3 Receptors linked to other enzymatic activities 
Majority of the enzyme-linked receptors stimulate protein-tyrosine phosphorylation. However, a number of 
receptors are associated with other enzymatic activities. The group includes protein-tyrosine phosphatases 
(Andersen et al., 2004), protein-serine/threonine kinases (reviewed in de Garcer et al., 2007) and guanylyl 
cyclases. Protein-tyrosine phosphatases remove phosphate groups from phosphotyrosine residues. They often 
have negative regulatory roles in cell signaling pathways by terminating the signals initiated by protein-tyrosine 
phosphorylation. Still many of them have a positive role in cell signaling. For example the surface molecule 
CD45, which is expressed on the surface of T and B lymphocytes belongs to the protein-tyrosine phosphatases. 
The group of protein-serine/threonine kinases contains TGF-β and some related polypeptides. Ligand-binding to 
these receptors leads to the association of two distinct polypeptide chains to form heterodimers in which the 
receptor kinases cross-phosphorylate each other. The activated receptors then activate further downstream 
signaling molecules. The receptor guanylyl cyclases have catalytic intracellular domains that catalyze the 
formation of a second messenger cyclic GMP. For example, nitric oxide acts by stimulating guanylyl cyclases. 
 
2.1.6 Constitutively active nuclear factors 
In addition to regulatory TFs there is a group of site-specific DNA binding proteins present in the cell nucleus of 
all cells all of the time (Brivanlou and Darnell, 2002). The group includes Sp1 (Briggs et al., 1986), CCAAT 
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binding protein (Chodosh et al., 1988; Johnson and McKnight, 1989), nuclear factor 1 (Driever and Nüsslein-
Volhard, 1989) and many others. These constitutively active nuclear factors have transcriptional activating 
potential. Still, they have not been implicated in changing the rates of individual gene transcription in a 
chromosomal context. They are supposed to facilitate the transcription of many chromosomal genes, possible 
genes that are constitutively transcribed, such as structural proteins tubulin and actin, and ubiquitous metabolic 
enzymes, such as glyceraldehyde phosphate dehydrogenase. These TFs are also able to participate in 
enhanceosomes together with TFs that are being regulated.  
 
2.1.6.1 Sp1 
Sp1 belongs to the constitutively active TFs (Turner and Crossley, 1999). It is ubiquitously expressed and it 
binds to GC-rich REs and therefore regulates a large number of so called housekeeping genes that have GC-rich 
promoters (Black et al., 2001). Sp1-like family factors regulate transcription by interacting with CoAs, like CBP, 
involving histone acetylation (Song et al., 2002; Zhang et al., 2001). 
 
2.2 Target genes 
 
The total number of transcriptional regulators and signaling pathways regulating gene expression in humans is 
huge. It is also known that the same stimulus affects different genes differently. Even though Métivier and co-
workers provided a model of the general features of transcriptional activation on chromatin level (Métivier et al., 
2003) it can be speculated that there is not a general model that applyes to all genes in all situations. As well, 
each gene contains many REs for different TFs. That makes it interesting to speculate that not only each gene has 
a unique pattern of transcriptional regulators but also each RE on the regulatory regions of the gene might be 
unique in how it recruits transcriptional co-regulators. 
 
In order to get a broader understanding of the events of transcriptional regulation, two totally different genes, 
human HAS2 and CYCLIN C, were selected as candidate genes. In addition to different functions of the proteins 
encoded by the two target genes, also the expression levels of HAS2 and CYCLIN C genes differ HAS2 having a 
much lower basal expression level than CYCLIN C. Studying the regulation of two such different genes should 
give more information of the general mechanisms of gene expression than studying just one gene. 
 
2.2.1 HAS2  
HAS2 is an enzyme making hyaluronan. Hyaluronan (also called hyaluronic acid or hyaluronate) is a linear high 
molecular mass non-sulfated polysaccharide (Tammi et al., 2005). It is composed of repeating disaccharide of D-
glucuronic acid and N-acetylglucosamine: [β1,4-GlcUA-β1,3-GlcNAc-]n (Fig. 8). The number of disaccharides 
usually varies leading to molecular weights of hyaluronan polymers between 2,000 and 25,000 Da. Hyaluronan 
is a major constituent of the vertebrate extracellular matrix. It has multiple physiological and cellular roles due to 
its unique biophysical and interactive properties (Toole, 2002). Its charge characteristics and polymeric 
properties contribute in many ways to tissue homeostasis and biomechanics. The interactions with other 
extracellular macromolecules (such as aggregating proteoglycans) are crucial to the assembly and integrity of 
Kuopio Univ. Publ. C. Nat. and Environ. Sci. 221: 1-102 (2007) 39
Katri Saavalainen: Evaluation of the mechanisms of gene regulation on the chromatin level at the example of human 
hyaluronan synthase 2 and cyclin c genes 
_____________________________________________________________________________________________________ 
extracellular and pericellular matrices. Its interactions with cell surface receptors, such as CD44 and hyaluronan-
mediated motility receptor, influence the cell behaviour in many morphogenetic and physiological systems. 
Hyaluronan is involved in maintenance of tissue architecture, cell proliferation, migration, differentiation, 
angiogenesis, wound healing and also tumorigenesis (Tammi et al., 2002). In addition, increased levels of 
hyaluronan in tissues and body fluids can be detected in several inflammatory conditions, such as lung fibrosis, 
rheumatoid arthritis, myocardial infarction and transplant rejection as well as in some invasive tumours. 
 
 
 
 
 
 
 
 
 
 
Fig. 8. Hyaluronan structure (http://www.glycoforum.gr.jp/science/hyaluronan/HA23/HA23E.html). The basic unit of 
hyaluronan is a disaccharide consisting of D-glucuronic acid and N-acetyl-D-glucosamine. These are linked by a glucuronidic 
β (1-3) bond. The disaccharide units are then polymerized by hexosaminidic β (1-4) linkages. 
 
2.2.1.1 Hyaluronan synthases 
Hyaluronan is highly metabolically active. Its half-life in humans ranges from less than one day to several days 
(Weigel et al., 1997). Hyaluronan is synthesized at the plasma membrane by monomeric enzymes called 
hyaluronan synthases (HASs), which are located at the plasma membrane. Three different genes that produce 
HAS enzymes have been identified in mammalian cells and are called, HAS1, HAS2 and HAS3. In the human 
genome HAS1 is on chromosome 19, HAS2 on chromosome 8 and HAS3 on chromosome 16. The three Has 
enzymes are related to each other but have distinct enzymatic properties, which suggests a different physiological 
role for each synthase (Itano et al., 1999). They differ from each other in stability, elongation rate of hyaluronan 
and apparent Km values for the two substrates (UDP-GlcNAc and UDP-GlcA). They are also expressed 
differentially in several cell types and show an idiotypic response to growth factors (Jacobson et al., 2000). The 
Has enzymes have extremely short half-lives of 2 to 4 h. Moreover, Has enzyme activity has been shown to be 
6.5-times higher in the exponential growth phase than in the stationary growth phase of cells (Zhang et al., 
2000). 
 
2.2.1.2 Regulation of hyaluronan synthesis 
Understanding the regulation of hyaluronan synthesis is important because of the important roles of hyaluronan 
in normal physiology and in disease. The mechanisms that regulate hyaluronan synthesis in normal tissues and in 
pathological processes, such as tumor metastasis and inflammatory foci are not fully understood. Several groups 
have found that growth factors, such as platelet-derived growth factor-BB, TGF-β1, IGF, fibroblast growth 
factor, follicle-stimulating hormone and EGF regulate hyaluronan synthesis in various cells of mesenchymal 
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origin (Jacobson et al., 2000; Pienimäki et al., 2001). The growth factors mediate their stimulatory effects on 
hyaluronan synthesis partly through the activation of PKC and PKA (Suzuki et al., 1995; Klewes and Prehm, 
1994). The influence of growth factors is specific for each cell type and may also depend on the stage of the 
cellular differentiation. The expression of the HAS genes has been shown to be higher in sub-confluent cultures 
compared with growth-arrested cultures (Jacobson et al., 2000). Also some NR ligands, such as all-trans RA and 
glucocorticoids, have been observed to modulate its synthesis rate (Tammi et al., 1989; Zhang et al., 2000). 
 
Of the three Has enzymes, Has2 is thought to be the main regulator of the hyaluronan synthesis. The proximal 
promoter region of its gene shows lower levels of constitutive activity compared to HAS1 and HAS3 proximal 
promoters making it more potent target of regulation (Monslow et al., 2004).  
 
2.2.2 CYCLIN C 
Cyclin C belongs to the cyclin protein superfamily the members of which are the main regulators of the 
eukaryotic cell cycle (Johnson, 1999). The regulation of cell cycle happens by sequential assembly and activation 
of the family serine-threonine protein kinases, the CDKs (Villiard et al., 2001). Cyclins are needed to activate the 
CDKs. Cyclin binding to CDKs introduces a conformational change that leads to the activation of the enzyme. In 
addition cyclins activate kinases that phosphorylate CDKs to make them fully active (Murray, 2004). Mammals 
have in total 18 cyclin proteins and nine CDKs. Many of the cyclins are very similar to each other and capable of 
activating the same CDKs.  
 
Cyclin C has a role in many processes as it is known to activate two different kinases, CDK3 and CDK8. Cyclin 
C/CKD3 complex causes the arrested G0 phase cells to go trough G0 to G1 transition. This transition is possible 
as CDK3 phosphorylates the well-known tumor suppressor Rb (Weinberg, 1995). The actions of the other Cyclin 
C complex, Cyclin C/CDK8, are better understood. Cyclin C/CDK8 complex regulates the transcriptional 
activity of a cell. The complex has been demonstrated to be associated with the Pol II basal transcriptional 
machinery (Rickert et al., 1996). The complex is also known to be a subunit of the MED complex. MED proteins 
form big complexes consisting of seven to eighteen subunits differing among the subunit composition (Rachez et 
al., 2001; Bourbon et al., 2004). Cyclin C is involved in high molecular mass MED complexes (Wang et al., 
2001). The MED complexes containing CDK8/Cyclin C were shown to be able to inhibit transcription (Sun et 
al., 1998; Akoulitchev et al., 2000). The inhibition is mediated through two different kinase activities of CDK8. 
CDK8 can phosphorylate the C-terminal domain of Pol II leading to the inhibition of transcription. When the 
CTD of Pol II is phosphorylated, it cannot form a transcription pre-initiation complex (Lu et al., 1991). CDK8 
can also phosphorylate the general transcription initiation factor II H (TFIIH) inhibiting the transcription-
activating role of Cyclin H/CDK7. There is also recent evidence of CDK8 as a part of MED complex being a 
positive regulator of transcription (Furumoto et al., 2007). In addition to being a general regulator of 
transcriptional activity in cell, Cyclin C is also linked to tumorigenesis (Li et al., 1996) and to Alzheimer’s 
disease (Ueberham et al., 2003). The CYCLIN C gene is known to be regulated by 1α,25(OH)2D3 (Polly et al., 
2000; Verlinden et al., 2000). 
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2.2.2.1 Cell cycle 
Each cell replicates its DNA and divides into two daughter cells during cell cycle (Johnson, 1999). The 
mammalian cell cycle consists of four distinct phases that need to take place in a well-defined order and each 
need to be completed successfully until the next phase can start. The starting point of the cycle is the G1, or gap1 
phase. During G1 phase cell needs to decide on the basis of different signals, whether to continue proliferation or 
to exit cell cycle into G0 phase during which proliferation does not continue. If the different mitogenic signals 
surpass growth inhibitory signals the cell commits for another cell cycle and starts to prepare the entry into the S 
(or synthesis) phase during which DNA is replicated. The S phase is followed by the G2 phase during which the 
integrity of DNA is checked and the cell prepares the final fourth phase, mitosis (M). During mitosis the cell 
divides into two daughter cells, which have to do the decision between proliferation and differentiation. 
 
2.3 General features of co-regulator function 
 
CoA and CoR complexes are acting as sensors that integrate signaling inputs to generate precise and complex 
programs of gene expression. Co-regulators contain enzymatic activities that are required for modification of the 
integral components of the co-regulator complexes and are also involved in modifications of the components of 
the basal transcriptional machinery and chromatin at target gene promoters. Many CoAs and CoRs are 
components of multi-subunit co-regulator complexes possessing a multitude of enzymatic activities. The 
complexes can be divided in two classes. Complexes of the first class consist of enzymes that can covalently 
modify histone tails such as acetylating/deacetylating activities (HATs and HDACs), methylating/demethylating 
enzymes (HMTs (Jenuwein and Allis, 2001)), protein kinases, protein phosphatases, poly(ADP)ribosylases, 
ubiquitin and SUMO ligases. The second class contains the components of a family of ATP-dependent 
remodelling complexes such as the SWI/SNF complex that alters the structure of the nucleosome in an ATP-
dependent manner most likely by modifying the histone-DNA interface that often leads to nucleosome sliding 
(Peterson, 2002).  
 
Co-regulator complexes are thought not to be TF-specific. Many co-factors are known to mediate the actions of 
numerous different classes of TFs (Glass and Rosenfeld, 2000). In addition, several TFs are able to use distinct 
combinations of co-factors depending on the cell type, promoter, DNA-binding site and the actions of various 
signaling pathways and ligands (Hermanson et al., 2002). 
 
The signal-dependent interactions of co-regulators with sequence-specific TFs are controlled at several levels, 
including the expression levels of co-regulators, post-translational modifications of co-regulators and their targets 
and for NRs there is control by ligand binding. Covalent modifications including phosphorylation, acetylation, 
sumoylation, ubiquitination and poly(ADP)ribosylation of DNA-binding factors (Rochetty-Egly et al., 1997) and 
CoAs such as CBP and E1A-binding protein (p300), are critical aspects of regulation (Yaciuk and Moran, 1991; 
Banerjee et al., 1994; Chakravarti et al., 1999). For example, CREB activates target genes in part through direct 
interactions with the KIX domain of the CoA CBP. This interaction has been shown to be dependent upon 
phosphorylation (Radhakrishnan et al., 1997; Impey and Goodman 2001; Mayr et al., 2001). Similarly, CoRs, 
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including NCoR1 and silencing mediator for retinoid and thyroid hormone receptors (SMRT/NCoR2) are 
modulated by phosphorylation (Hong and Privalsky, 2000) and sumoylation. 
 
There is known to be signal-dependent, temporal-specific factor exchange (Cosma, 2002). The first example 
came from studies of the HO locus of budding yeast, in which an ordered recruitment of SWI5 an SBF, the 
SWI/SNF complex, the SAGA complex and finally the Ash1 repressor was reported. This ordered exchange both 
defines the sequence in recruitment of enzymatic machinery necessary to achieve activation of specific 
transcription units and also provides a temporally chancing complement of potential sensors for responding 
changes in the signaling milieu of the cells. It is now widely accepted that the active exchange cycles of 
sequence-specific TFs and associated co-regulators are required for sustained transcriptional responses in 
signaling inputs in metazoan organisms. 
 
Signal-dependent turnover has been correlated with transcriptional activation for several NRs. Proteasome-
mediated degradation and ligand-dependent transactivation are reported to be linked and act continuously, in the 
case of both RAR (Kopf et al., 2000) and VDR (Masuyma and MacDonald, 2000; Li et al., 1999). Also some 
CoAs such as receptor associated CoA3 can be targeted for degradation by ubiquitinylation/proteasome pathways 
(Morris et al., 2003; Gillette et al., 2004; Li et al., 2006). 
 
The dynamics of these processes are still to some extent unclear and a common model of the recruitment of 
transcriptional regulators and chromatin modifiers still does not exist. Métivier and co-workers have studied the 
dynamics of co-factor recruitment to human pS2 gene promoter in response to estrogens (Métivier et al., 2003). 
They concluded transcriptional activation to be a cyclic process involving both activating and repressive 
epigenetic processes. They defined the concept “transcriptional clock” that is supposed to direct and achieve the 
sequential and combinatorial assembly of transcriptional regulators on a promoter. The initial cycle of ERα 
recruitment is transcriptionally unproductive process that is required for promoter commitment. Nucleosome 
remodeling complex SWI/SNF is recruited to pS2 promoter following by the recruitment of HMTs, HATs and 
then the components of basal transcriptional machinery. This step finally leads to proteosomal degradation of 
ERα. The degradation step happens at the end of each cycle and is followed by histone deacetylation prior to the 
initiation of following cycles. The cycle following the initial cycle is transcriptionally productive. This cycle 
starts by the recruitment of p68 RNA helicase following combinatorial sequestering of HMTs, p160 and HATs 
that ultimately form a large complex on the promoter that then directs and achieves further posttranslational 
modifications of histones. This is followed by the recruitment of TR-associated protein (TRAP)/MED complex 
which promotes the phosphorylation of Pol II and transcriptional initiation. 
 
2.3.1 CoAs 
There are different groups of CoAs differing from each other by their structure and function. Some of the CoAs 
serve as adaptors between NRs or some other TFs and the basal transcriptional machinery. Many of the CoAs 
have enzymatic activities, such as HAT activity or HMT activity, which target histones for acetylation or 
methylation, respectively. HAT activities containing CoAs include the members of the steroid receptor CoA 
(SRC) family, SRC-1, transcription intermediary factor 2 and receptor-associated CoA3. In addition to them also 
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p300 and CBP are CoA possessing HAT activity. HMTs include CoA-associated arginine methyltransferase I 
and protein arginine methyltranferase I. CoAs can also serve as bridging factors that make a connection from 
even a far distant NR to the basal transcription machinery. For example, TRAP220 serves as a bridging factor for 
many NRs. 
 
Nucleosome remodelling factors are protein complexes that weaken the tight wrapping of DNA around the 
histone octamers facilitating the sliding of histone octamers to neighboring DNA segments (Becker and Hörz, 
2002). For example, brahma-related gene 1 is a CoA that forms a part of nucleosome remodelling complex. It is 
known to be a central regulator of the cell cycle and tumor suppression due to its direct interactions with Rb and 
several cyclins and CDKs (Shanahan et al., 1999; Bochar et al., 1999). 
 
Some CoAs are involved in the ubiquitin proteasome pathway. These CoAs include receptor potentating factor 1, 
E6-associated protein, ubiquitin conjugating enzyme 7, suppressor of Gal4-thyroid hormone interacting protein 
1, MB67-interacting protein 224 and TBP-1. There are also a variety of CoAs that are involved in splicing 
control and some that can be classified as signal-integrating CoAs. The former group includes among others CoA 
activator and CoA of AP-1 and ERs and the latter includes proteins such as the transducer of regulated CREB 
activity 2. 
 
2.3.2 CoRs 
CoRs are proteins whose interaction with NRs lowers the transcription rate of their target genes (Burke and 
Baniahmad, 2000). Several NRs, including RAR, VDR and TR, bind to DNA of their target genes already in the 
absence of ligand and actively repress transcription. Those NRs often bind to DNA in the complex with either 
NR CoR 1 (NCoR1) or SMRT (NCoR2). Both NCoR1 and SMRT contain transferable repression domains and 
are supposed to work as CoRs by recruiting a complex containing Sin3, HDACs and also some other proteins 
(Hörlein et al., 1995; Chen and Evans, 1995). The roles of NCoR1 and SMRT have expanded also to many other 
transcriptional repression events than that of NRs (Xu et al., 1998). They can also function as CoRs for 
homeodomain repressors Rpx and Msx-1 (Woloshin et al., 1995) and they can repress the transcription of genes 
that are a result of Notch-Delta pathway activation (Kao et al., 1998). 
 
NcoR1 and SMRT localize mainly in the nucleus. Still, it has been suggested that they can be post-translationally 
modified which in turn can lead to nuclear-cytoplasmic shuttling of these CoRs. SMRT is known to be 
phosphorylated by MAPK-directed pathway and in the case of NCoR1, phophorylation of an associated protein 
TAB2 by IKK kinase induced nuclear exit (Hong et al., 2001; Baek et al., 2002). 
 
In addition to NCoR1 and SMRT, the group of CoR proteins include also other proteins: thyroid hormone 
receptor interactor 15 (Alien), small unique NR CoR and homolog of mouse hairless (Hairless) that is involved 
specifically in the regulation of hair development. 
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3. Aims of this study 
 
When this thesis was started the regulation of the human HAS2 gene in general and in particularly on chromatin 
level, was not understood in detail. There was practically no information concerning the chromatin level events 
affecting HAS2 gene expression. Also the regulation of another important gene, human CYCLIN C, was not 
characterized in detail. In addition, there was still a lot to clarify concerning the mechanisms of gene expression 
on the chromatin level in general.  
 
Therefore the specific aims of this study were: 
 
1. To investigate the regulation of human HAS2 gene expression in response to all-trans RA, EGF, 
TNFα and Forskolin both on mRNA and chromatin level. 
 
2. To study the chromatin composition of the 1α,25(OH)2D3 responsive regions on the human CYCLIN 
C promoter. 
 
3. To investigate the regulation of human CYCLIN C gene by all-trans RA and Forskolin both on 
mRNA and chromatin level. 
 
4. To compare the regulation of the two different genes, HAS2 and CYCLIN C, on chromatin level. 
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4. Materials and methods 
 
4.1 Materials 
 
4.1.1 Ligands, inhibitors and recombinant proteins 
The roman numerals used in the following sections refer to the four studies forming the theses. All-trans RA (I, 
III, IV) and EGF (I) were purchased from Sigma-Aldrich (St. Louis, MO, USA). The EGFR kinase inhibitor 4-
(3’-chloroanilino)-6,7-dimethoxyquinazoline, AG1478 (I), was from LC Laboratories (Woburn, MA). 
1α,25(OH)2D3 (II) was kindly provided by Dr. L. Binderup (LEO Pharma, Ballerup, Denmark). Recombinant 
TNFα (III), IKK-2 inhibitor (III) and Forskolin (IV) were purchased from Calbiochem (Läufelfingen, 
Switzerland). Recombinant STAT1 (I) was from Lab Vision (Fremont, CA). 1α,25(OH)2D3 was dissolved in 2-
propanol, TNFα in H2O, whereas the other compounds were dissolved in DMSO. Further dilutions were made in 
DMSO or in EtOH as indicated in the original articles. 
 
4.1.2 Cells 
Table 1. Growth conditions for the cell lines used in the studies 
 
Cell line  Medium  FBS (%) Used in 
HaCaT   DMEM   10  I, III, IV 
REK   DMEM   10  I 
HEK293  DMEM   10  IV 
MCF-7   α-MEM   5  II 
 
4.1.3 DNA constructs 
Protein expression constructs 
In vitro transcription/translation of the respective cDNAs and the overexpression of the respective proteins in 
mammalian cells were done using T7 RNA polymerase-driven mammalian expression vectors. The full-length 
cDNAs for human RARγ (Schräder et al., 1993) and human RXRα (Mangelsdorf et al., 1990) were sub-cloned 
previously into the T7/SV40 promoter driven pSG5-expression vectors (Stratagene, La Jolla, CA). The full-
length cDNA for human CREB was subcloned into T7/SV40 promoter driven pFN2-expression vector and was 
purchased from Origene (Rockville, USA). The full-length cDNAs for human p50 and p65 proteins were 
subcloned into T7/SV40 promoter driven pcDNA3-expression vector and were kindly provided by Prof. M.L. 
Schmitz (Justus-Liebig-University, Giessen, Germany). 
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Reporter gene constructs 
The core sequences of the REs and the promoter fragments are indicated in the original articles. They were fused 
to the thymidine kinase promoter driving the firefly luciferase gene (LUC) in a pGL3-(apart from Cyclin C 
promoter fragments in IV) derived Luciferase Reporter Vector (Promega, Madison, WI, USA), The nested set of 
HAS2 promoter fragments (III and IV) was kindly provided by Dr. T. Bowen (Cardiff University, Cardiff, United 
Kingdom) (Monslow et al., 2004). The XbaI-restriction site at nucleotide position 1742 of pGL3 had been 
removed from the original vector by mutagenesis. The individual REs were cloned as a two-copy constructs of 
the RE to the remaining XbaI cloning site. The fragments of the human CYCLIN C promoter (II) were cloned by 
PCR from human genomic DNA using primers with SacI (forward primer) and XbaI (reverse primer) restriction 
sites. The promoter fragments for human CYCLIN C promoter used in the fourth original publication were cloned 
by PCR from human genomic DNA using primers with Kpn I (forward primer) and Nhe I (reverse primer) 
restriction sites and fused to the thymidine kinase promoter driving the firefly luciferase gene in a pGL4-derived 
luciferase reporter vector. 
 
4.2 Methods 
 
4.2.1 In silico promoter analysis 
The first 10 kb (I) or 2250 bp (III and IV) of the human HAS2 promoter was screened in silico for putative RAR 
(I, III, IV), STAT (I), Sp1 (III), NF-kB (III) and CREB1 (IV) binding sites. The first 2250 bp (IV) of human 
CYCLIN C promoter was screened for putative RAR (IV) and CREB (IV) binding sites. Putative RAREs were 
identified by screening the promoter for two copies of RGKTCA consensus sequence in a DR5 arrangement. The 
maximal deviation from the consensus sequence was restricted to one position. Putative Sp1, NF-κB and CREB1 
binding sites were screened by using the net-based program ConSite (http://mordor.cgb.ki.se/cgi-
bin/CONSITE/consite/) with a TF score cutoff of 85 %. The putative REs found on these criteria are described in 
the individual publications. The nucleotide positions referred to in the position of the found putative REs are 
respective to the indicated gene’s TSS, with negative values assigned to sequence found upstream from the gene. 
 
4.2.2 In vitro methods 
4.2.2.1 In vitro transcription and translation 
Human RARγ and RXRα proteins were generated by coupled in vitro transcription/translation using their 
respective pSG5-based full length cDNA expression constructs (Schräder et al., 1993; Carlberg et al., 1993) and 
rabbit reticulocyte lysate as recommended by supplier (Promega, Madison, WI, USA). The reaction set up is as 
follows: 
 
25 μl rabbit reticulocyte lysate, nuclease treated 
1 μl amino acid mix (1 mM) 
1 μl RNase inhibitor (40 U/μl, Fermentas) 
10 μl rNTPs (5 mM) 
6 μl MgCl2 (25 mM) 
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5 μl template DNA (0.4 μg/μl) 
1 μl T7 RNA polymerase (20 U/μl, Fermentas) 
 
The in vitro transcription/translation reactions were incubated for 90 min at 30 °C. Protein batches were 
quantified by test translation in the presence of [35S]-methionine. For the experiments the specific protein 
concentrations were adjusted to 4 ng/μl (10 ng corresponds approximately to 0.2 pmol) after taking the 
individual number of methionine residues per protein into account. 
 
4.2.2.2 Nuclear extracts preparation 
For nuclear extract preparation, HaCaT cells were seeded into 175 m2 culture bottles and grown overnight in 
DMEM supplemented with 5 % (w/v) charcoal-treated FBS to reach a density of 60 to 70 %. At the start of 
experiment the medium in the bottles was reduced to 10 ml. Cells were treated for 20 min with solvent or 20 
ng/ml TNFα (Calbiochem, Läufelfingen, Switzerland) with or without 10 μM IKK-2 inhibitor (Calbiochem, 
Läufelfingen, Switzerland). Cells were harvested by mechanical scraping into 5 ml of PBS. Cell pellets were 
resuspended in 0.5 ml of low salt buffer (10 mM Hepes, pH 7.9, 1.5 mM MgCl2, 50 mM KCl, 0.5 mM 
dithiothretiol, proteinase inhibitors). Cells were then resuspended in 2-3 packed volumes of the same low salt 
buffer with 0.5 % NP40 and homogenized by pipetting on ice. The nuclear pellet was then resuspended in one 
packed cell volume of high salt buffer (10 mM Hepes, pH 7.9, 25 % glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 
mM EDTA, 0.5 mM DTT, proteinase inhibitors). Extraction was performed for 30 min on ice.  
 
4.2.2.3 Gel shift assay 
Gel shift assays were performed with 10 ng of in vitro translated proteins using the molar ratio 1:1 (4 μl RARγ 
and 1 μl RXRα), with 10 μg of the nuclear extracts or with 750 ng of recombinant STAT1 protein (1.5 μl from a 
0.5 mg/ml stock, adjusted to 5 μl with H20). The proteins were incubated at room temperature (RT) for 15 min in 
binding buffer containing 2.5 μl 1 M KCl, 4 μl 5 x gelshift buffer (10 mM Hepes, pH 7.9; 1 mM dithiothretiol, 
25 ng/μl herring sperm DNA (Promega), 5 % glycerol) and the reaction volume was adjusted to 18 μl with H20. 
Double-stranded oligonucleotides were labeled by a Klenow fragment DNA polymerase (Fermentas, Vilnius, 
Lithuania)-mediated filling in reaction in the presence of a nucleotide mixture containing radio-labeled [32P]-α-
dCTP. Constant amounts (1 ng) of [32P]-labeled oligonucleotides (50 000 cpm) were incubated with the nuclear 
extracts for 20 min at room temperature (RT). Antibodies were added 15 min after the nuclear extracts to the 
DNA. Protein-DNA complexes were resolved by electrophoresis through 5 (STAT) of 8 % non-denaturing 
polyacrylamide gels in 0.5 x TBE (45 mM Tris, 45 mM boric acid, 1 mM EDTA (pH 8.3)) and quantified on a 
Fuji FLA3000 (Fuji, Tokyo, Japan) reader using the ScienLab99 software package (Fuji). 
 
4.2.2.4 Transfection  
HaCaT and HEK293 cells were seeded into 6-well plates (I, III, IV) or into 96-well plates (IV) and grown 
overnight in DMEM supplemented with 5 % (w/v) charcoal-treated FBS to reach a density of 60 to 70 %. 
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Transfection with DOTAP 
In DOTAP (N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium methylsulphate) transfection 10 μg (for 
6-well plates ) or 0.5 μg (for 96-well plates) of DOTAP was incubated for 15 min at RT with 1 μg or 0.04 μg of 
the reporter plasmid and 1 μg or 0.04 μg of pSG5-, pcDNA3-, or pFN2K-based expression vectors in a total 
volume of 100 μl or 20 μl for 6-well plates or for 96-well plates, respectively. After the 15 min incubation 900 μl 
(for 6-well plates) or 80 μl (for 96-well plates) of phenol red-free Dulbecco’s modified Eagle’s medium 
(DMEM) was added. Medium was replaced and the transfection medium was added. Ligands were added in 
phenol red-free DMEM supplemented 5 % FBS 4 h after transfection. 
 
Transfection of siRNAs with Polyethylenimine (PEI) 
PEI (Sigma-Aldrich) was used to transfect siRNAs into HEK293 cells (IV). siRNA mixtures used were 
composed of equal amounts of three different siRNA molecules against CBP, MED1 or NCoR1 in addition to 
control. 200 pmol of each siRNA molecule was incubated for 15 min with 50 μl of 150 mM NaCl (for 6-well 
plates). Simultaneously, 10 μg of PEI was incubated with 50 μl of 150 mM NaCl. After the 15 min incubation, 
both solutions were combined and the mixture was incubated for an additional 15 min. After that 900 μl of 
phenol red-free DMEM supplemented with 1 % glutamine was added per one well of a 6-well plate. Medium 
was replaced and the transfection medium was added. Ligands were added in phenol red-free DMEM 
supplemented with 5 % FBS 48 h after transfection. The silencing effect was checked by real-time PCR. 
 
4.2.2.5 Luciferase reporter gene assay 
In the reporter gene assays on 6-well plates (I, III) cells were washed twice with ice-cold PBS (140 mM NaCl, 
2.7 mM KCl, 1.5 mM KH2PO4, 8.1 mM Na2HPO4•H20) and lysed with 200 μl of reporter gene lysis buffer 
(Roche) 16 h after ligand addition to transfected cells. The lysis was collected and the cells pelleted by 
centrifuging for 15 min with 20,000 x g at RT. In order to measure the luciferase activity, 150 μl of the lysate 
was combined with 100 μl of luciferase substrate (in Luciferase Reporter Gene Assay buffer, Canberra-Packard, 
Groningen, Netherlands) and measured with the Highpass filter. The total protein amount was measured by 
taking 10 μl of the lysate and combining it with 200 μl of Protein Assay buffer (Biorad, München, Germany). 
The absorbance was measured at 595 nm. A 96-well plate reader luminometer (Anthos Labtec Instruments, 
Wals/Salzburg, Austria) was used in the measurements in I and III.  
 
In the 96-well plated method (IV), 16 h after ligand addition, the medium was removed from the cells and the 50 
μl of luciferase substrate (Luciferase Reporter Gene Assay buffer, Canberra-Packard, Groningen, Netherlands) 
was added to the cells and measured with Victor3 multi-label reader (PerkinElmer Life and Analytical Sciences, 
Shelton, USA). The total protein amount was measured by adding 50 μl of Protein Assay buffer (Biorad, 
München, Germany) to cells containing the luciferase substrate. The absorbance was measured at 595 nm with 
Victor3. 
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4.2.3 Ex vivo methods 
4.2.3.1 RNA extraction 
Cells were seeded into 100 m2 bottles (I) or 6-well plates (III, IV) and grown overnight to reach a density of 60 to 
70 %. Ligand stimulation was done like indicated in the individual publications 
 
Total RNA extraction (I) 
Total RNA was extracted using Tri-reagent (Sigma-Aldrich). 1 ml of Tri-reagent was used for approximately 5 x 
106 cells. 0.2 ml of chloroform was added to separated the mixture into 3 phases: an aqueous phase containing 
RNA, the interphase containing DNA and an organic phase containing proteins. After 2 min incubation at RT the 
mixture was centrifuged for 15 min at 4 °C with 12,000 x g. The supernatant containing RNA was taken into a 
new tube and RNA was precipitated by adding 0.5 ml isopropanol. After incubation for 10 min at RT the 
precipitated RNA was pelleted by centrifuging for 10 min at 4°C with 12,000 x g. The RNA pellet was washed 
with 1 ml of 75 % ethanol and dissolved in 100 μl sterile water. 
 
mRNA extraction (I)  
mRNA was extracted from the total RNA by using Oligotex mini mRNA kit (Qiagen, Hilden, Germany). To 
isolate mRNA 150 μl of RNase free water, 250 μl of binding buffer (20 mM Tris-HCl, (pH 7.5), 1 M NaCl, 2 
mM EDTA, 0.2 % SDS) and 15 μl of Oligotex suspension were added for 100 μl of total RNA. Oligotex 
suspension contained oligodT particles suspended 10 % (w/v) in solution containing 10 mM Tris-HCl (pH 7.5), 
500 mM NaCl, 1 mM EDTA, 0.1 % SDS, 0.1 % NaN3. To allow Oligotex-mRNA complexes to form, samples 
were heated at for 5 min at 70°C and incubated for 10 min at RT. Complexes were then pelleted by centrifuging 
for 2 min with 14,000 x g at RT. The pellets were washed by resuspensing the Oligotex: mRNA pellets in 400 μl 
of washing buffer (10 mM Tris-HCl, (pH 7.5), 150 mM NaCl, 1 mM EDTA) and the suspension was removed to 
a spin column placed in an Eppendorf tube. After centrifugation for 1 min with 14,000 x g at RT, the spin 
column was transferred to a new RNase-free tube and the washing step was repeated. After centrifugation the 
spin column was transferred to a new RNase-free tube and mRNA was eluted by adding 100 μl of hot (70 °C) 
elution buffer (Buffer OEB: 5 mM Tris-HCl (pH 7.5)) onto the column and by centrifuging for 1 min with 
14,000 x g at RT. The elution step was repeated. RNA yield and purity were determined by A260/A280 ratio. 
 
Total RNA extraction with the Mini RNA Isolation II kit (III, IV) 
RNA was extracted from the cells directly with RNAeasy kit (HiSS Diagnostics, Freiburg, Germany). Cells were 
washed twice with ice-cold PBS. Cells were then lysed with 600 μl of ZR RNA buffer and collected into 
columns placed in Eppendorf tubes. The column was centrifuged for 1 min with 14,000 x g at RT. After that the 
RNA was washed twice with RNA wash buffer and the RNA was eluted with 50 μl of sterile water. Total RNA 
amount was measured with NanoDrop ND-1000 (NanoDrop, USA). 
 
4.2.3.2 cDNA synthesis 
cDNA synthesis was performed using 100 pmol of oligodT18 primer in the presence of reverse transcriptase 
(Fermentas). Sample reactions were prepared using 100 ng of mRNA (I, II) or 1 μg of total RNA (III, IV) as a 
template, 4 μl of 5 mM dNTPs, 2 μl of 0.1 M DTT, 8 μl of 5 x reverse transcriptase buffer (250 mM Tris-HCl 
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(pH 8.3), 250mM KCl, 20 mM MgCl2, 50 mM DTT) (Fermentas), 2 μl of reverse transcriptase (20 U/μl), 1 μl of 
RNAse inhibitors (40 U/μl) and H2O to a final reaction volume of 40 μl. cDNA was synthesized for 1 h at 37 °C 
followed by an inactivation for 5 min at 95 °C. The cDNA was diluted 1:10 in H2O. 
 
4.2.3.3 Real-time PCR 
Real-time quantitative PCR was performed in an IQ-cycler (BioRad, Hercules, CA, USA) using the dye 
SybrGreen (Molecular Probes, Leiden, The Netherlands). The reaction set up is as follows: 
 
2.2 μl 10 x reaction buffer (HotStart PCR buffer (Fermentas in I and II), FastTaq PCR buffer (Roche) in III and 
IV) 
2.4 μl 25 mM MgCl2  
0.4 μl 10 mM dNTPs 
1 μl SybrGreen (1:2500 dilution from the stock) 
0.2 μl HotStart / FastTaq DNA polymerase (5 U/μl) 
8 μl H2O 
1 μl primer mix (10 μM) 
 
PCR primers and primer-specific annealing temperatures are described in the individual papers. PCR cycling 
conditions were: 
 
1. Denaturation for 5 min at 95 °C 
2. PCR amplification repeated for 40 cycles 
 Denaturation for 30 s 95 °C 
 Annealing for 30 s at primer-specific annealing temperatures 
 Elongation for 40 s at 72 °C 
3. Final elongation for 10 min at 72 °C 
4. Denaturation for 1 min at 95 °C 
 
PCR product quality was monitored using post-PCR melt curve analysis at the end of the amplification cycles. 
Fold inductions were calculated using the formula 2-(ΔΔCt), where ΔΔCt is the ΔCt(stimulant)- ΔCt(solvent), ΔCt is Ct(test 
gene)-Ct(control gene) and Ct is the cycle at which the threshold is crossed. 
 
4.2.3.4 Chromatin immunoprecipitation assay 
Cell were seeded into 175 m2 bottles and grown overnight to reach a density of 60 to 70 %. When starting the 
experiment 10 ml of the experiment medium was left into the bottles. The cells were then stimulated as indicated 
in the individual publications.  
 
Nuclear proteins were cross-linked to DNA by adding formaldehyde directly to the medium to a final 
concentration of 1 % for 15 min at RT (I and II) or for 10 min (III and IV). Cross-linking was stopped by adding 
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1.5 ml of glycine to a final concentration of 0.150 M and incubating for 5 min at RT on a rocking platform. The 
medium was removed and the cells were washed twice with ice-cold PBS. The cells were then collected by 
scraping into ice-cold PBS supplemented with a protease inhibitor cocktail (Roche). After centrifugation (5 min 
at 4 °C with 700 x g) the cell pellets were resuspended in 1 ml of lysis buffer (1 % SDS, 10 mM EDTA, protease 
inhibitors, 50 mM Tris-HCl, pH 8.1). Lysis was allowed to continue for 10 min at RT. The lysates were 
sonicated to result in DNA fragments of 300 to 1000 bp in length (1000 to 1500 bp for CYCLIN C region 3, IV). 
Cellular debris was removed by centrifugation for 15 minutes at 4 °C with 20,000 x g and the lysates were 
diluted 1:10 in ChIP dilution buffer (0.01 % SDS, 1.1 % Triton X-100, 1.2 mM EDTA, 16.7 mM NaCl, protease 
inhibitors 16.7 mM Tris-HCl, pH 8.1). 
 
Chromatin solutions were incubated with 5 µl (200 µg/ml) of specific antibodies and with 24 µg of sonicated 
salmon sperm DNA overnight at 4 °C with rotation. The antibodies used are described in the individual 
publications. For input samples, 50 µl of undiluted lysate was diluted with 450 µl of ChIP dilution buffer and 
processed like outputs from reverse cross-linking step onwards. 
 
The immune complexes were collected with 60 µl of salmon sperm DNA/protein A agarose slurry (Upstate 
Biotechnology, Lake Placid, USA) (I, II, III) or with salmon sperm DNA/protein G agarose slurry (Upstate) (IV 
for 1 h) at 4 °C with rotation. The beads were pelleted by centrifugation for 1 min at 4 °C with 100 x g and 
washed sequentially for 4 min on a rotating platform with 1 ml of the following buffers: low salt wash buffer (0.1 
% SDS, 1 % Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl, pH 8.1), high salt wash buffer (0.1 % 
SDS, 1 % Triton X-100, 2 mM EDTA, 500 mM NaCl, 20 mM Tris-HCl, pH 8.1) and LiCl wash buffer (0.25 mM 
LiCl, 1 % Nonidet P-40, 1 % sodium deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8.1). Finally, the beads 
were washed twice with 1 ml TE buffer (1 mM EDTA, 10 mM Tris-HCl, pH 8.0). The immuno-complexes were 
eluted by adding 500 µl of elution buffer (1 % SDS, 100 mM NaHCO3) and incubating for 30 min at RT with 
rotation. After centrifugation, the supernatant was collected and the cross-linking was reversed by adding NaCl 
to final concentration of 200 mM and incubation overnight at 65 °C (I, II and III). The remaining proteins were 
digested by adding proteinase K (final concentration 40 µg/ml, Invitrogen) and incubating for 1 h at 45 °C (I, II 
and III). The reverse cross-linking and protein digestion was done in the 4th article by adding 2 µl of proteinase K 
(final concentration 80 µg/ml, Fermentas) and incubating overnight at 65 °C. The DNA was extracted by adding 
500 µl of phenol/chloroform/isoamyl alcohol (25/24/1) and precipitated with 0.1 volumes of 3 M sodium acetate, 
pH 5.2 and 2 volumes of ethanol using glycogen as a carrier. The samples were dissolved in 60 µl of H2O. 
 
4.2.3.5 PCR of the chromatin templates  
Immunoprecipitated DNAs were used as templates for PCR. Primer-specific temperatures and cycling numbers 
and the locations of the primers are described in the original publications. The amounts of reaction components 
are described earlier in section 4.2.3.3. The PCR was performed using the following program: 
 
1. Denaturation for 5 min at 95 °C 
2. PCR amplification repeated for 30 to 45 cycles according to primers 
 Denaturation for 30 s at 95 °C 
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 Annealing for 30 s at primer-specific annealing temperatures 
 Elongation for 30 s at 72 °C 
3. Final elongation for 10 min at 72 °C 
4. Denaturation for 1 min at 95 °C. 
 
The products were resolved on 2 % TAE (200 mM Tris-HCl, pH 7.5, 100 mM acetate, 5 mM EDTA) gels. The 
gels were then imaged with Fuji FLA3000 reader using ImageGauge software, The intensities of the bands were 
measured using ImageJ 1.37V software (National Institutes of Health, USA) (III and IV). Output samples were 
normalized to their inputs and the non-specific IgG background was subtracted from the samples. The relative 
association levels were then calculated as % of input. 
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5. Results 
 
5.1. All-trans RA and EGF -mediated regulation of the human HAS2 gene 
(I) 
 
EGF stimulates hyaluronan synthesis rate in epidermal keratinocytes in monolayer and organotypic cultures and 
all-trans RA in human skin organ cultures (Pienimäki et al., 2001; Tammi et al., 1989). In skin epidermis the 
narrow extracellular space surrounding keratinocytes contains a high concentration of hyaluronan. The 
concentration of hyaluronan is closely correlated with the proliferative activity and volume of the vital part of the 
epidermis. It is inversely related with the markers of differentiation suggesting that hyaluronan synthesis 
regulated by Has enzymes is an important component in the proliferative reactions of the epidermis and is also 
involved in the epidermal differentiation process (Pasonen-Seppänen et al., 2003). Of the three Has enzymes, 
Has2 is the main regulator of hyaluronan production in epidermis. Therefore, in this study, HAS2 mRNA levels 
in response to all-trans RA, EGF and the EGFR inhibitor AG1478 alone or in combinations were measured in 
REK and HaCaT cells (I, Fig 2A and 2B, respectively). In REK cells both all-trans RA and EGF stimulated 
HAS2 mRNA expression approximately 4-fold after 2 h treatment and the combination of both stimuli resulted in 
a more than 8-fold induction. AG1478 application resulted in a slight but not significant induction of HAS2 
expression, whereas the combined treatment with all-trans RA and AG1478 showed a minor if any reduction of 
the all-trans RA response of the gene. In HaCaT cells all-trans RA and EGF stimulated human HAS2 mRNA 
levels 8.3- and 33-fold, respectively. The combined treatment resulted even in a 63-fold induction. AG1478 
reduced HAS2 mRNA expression to 18 % of solvent-treated cultures and its combination with all-trans RA 
resulted only in 1.6-fold induction.  
 
As both all-trans RA and EGF induced human HAS2 mRNA levels significantly, the first 10 kB of the HAS2 
promoter were screened in silico for RAR and STAT binding sites (I, Fig. 3A). For RAREs the promoter was 
screened for RGKTCA sequence in a DR5 arrangement. By restricting the maximal deviation from this 
consensus sequence to one position four DR5-type REs were found, at positions -1,207 to -1,225, -1,218 to -
1,236, -2,471 to -2,453 and -6,879 to -6,897. Allowing between two and six spacing nucleotides between a pair 
of the trimeric STAT recognition motif TTC, four putative STAT-REs were found. They were located at 
positions -379 to -387, -1,212 to -1,221, -1,864 to -1,871 and -7,014 to -7,025. 
 
To test the capability of these putative REs to bind RAR and STAT, gelshift assays were performed. Of the four 
putative STAT-REs only the RE closest to the TSS (-379 to -389) showed a significant binding of recombinant 
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STAT protein (I, Fig. 3.B). The binding of in vitro translated RARγ and RXRα either alone or in combination 
was assessed on the four putative RAREs in reference to an idealized DR5-type RARE (I, Fig. 3C). None of the 
four candidate REs showed significant binding of RAR-RXR heterodimer in vitro. However, in reporter gene 
assays the RARE cluster formed by RAREs 1 and 2 was able to mediate all-trans RA-dependent reporter gene 
induction that was comparable with that of the idealized DR5-type RARE (I, Fig. 3D). 
 
To investigate whether retinoid receptors and STAT proteins associate in live cells with the human HAS2 
promoter, ChIP assays were performed with all-trans RA and EGF stimulated HaCaT cells using antibodies 
against RARγ, STAT3 and pSTAT3. 60 min all-trans RA treatment induced RARγ association weakly to regions 
containing STAT-REs 1 and 2, the RARE cluster and RARE4 together with STAT-RE4 (I, Fig. 4). RARγ 
binding to region containing the RARE3 was increased hugely after 60 min exposure to all-trans RA. In the 
absence of all-trans RA STAT-RE1 containing region bound STAT3. Retinoid-treatment increased the binding 
there and also induced STAT3 and pSTAT3 binding to regions containing STAT-RE2 together with the RARE 
cluster and STAT-RE3. All-trans RA induced the association of STAT3 to RARE3 containing region and 
pSTAT3 to RARE4 and STAT-RE4 containing region. EGF stimulation only induced STAT3 and pSTAT3 
binding to STAT-RE1 conforming its role as the mediator of EGF-induction on the HAS2 promoter.  
 
In order to get a clearer picture of the retinoid-response of HAS2 promoter, ChIP assays were performed to check 
the association of RXR and co-regulators CBP, MED23, Pol II and pPol II. Additionally, the acetylated histone 4 
levels, as a marker of activated, open chromatin were measured (I, Fig. 5). RXR was found only in regions 
containing STAT-RE2 together with the RARE cluster and in region containing STAT-RE3. CBP binding, in 
contrast, was detected in all regions studied, apart from the negative control region. MED23 binding was 
constant in regions containing STAT-RE3 and in region containing STAT-RE4 in addition to RARE4. Regions 
containing STAT-RE 1 and STAT-RE2 in addition to the RARE cluster showed increased MED23 binding after 
retinoid treatment. Pol II showed the strongest association in region containing STAT-RE1, the binding was 
retinoid-dependent, as is was in the region containing RARE4 and STAT-RE4. The region containing the RARE 
cluster in addition to STAT-RE2 and the region containing STAT-RE3 bound Pol II constantly but weakly. The 
functionally more important form of Pol II, pPol II, showed similar behavior as Pol II in the region containing 
STAT-RE1. Also the region containing RARE4 and STAT-RE4 showed strong retinoid-induced binding of pPol 
II. After all-trans RA treatment pPol II was also recruited to the region containing the RARE cluster in addition 
to STAT-RE2 and the region containing STAT-RE3. The chromatin activation status was measured by acetylated 
histone 4 associations and was found to be high for all the regions studied. It was induced by all-trans RA only in 
the RARE cluster and the STAT-RE2 containing region. The association patterns of the nuclear proteins studied 
and the acetylation levels suggested that the region containing the RARE cluster and STAT-RE2 is the most 
likely promoter region mediating the action of all-trans RA on HAS2 gene induction.  
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5.2 Regulation of the human CYCLIN C gene by 1α,25(OH)2D3 (II) 
 
The human CYCLIN C gene is known to be regulated by 1α,25(OH)2D3 (Polly et al., 2000) However, the VDR 
binding sites and the mechanisms of 1α,25(OH)2D3-mediated response have not been characterized on the 
chromatin level. Screening of the promoter by ChIP assays identified in total four regions which bound VDR and 
its heterodimerization partner RXR constantly over a time period of 240 min. All those regions were shown to 
contain one functional VDRE. In order to get more details of the VDR complexes found on those VDRE 
containing regions, re-ChIP assays were performed with 1α,25(OH)2D3-stimulated MCF-7 cells using first an 
antibody against VDR, followed by antibodies against RXR, NCoA3, MED1 and pPol II, so that the chromatin 
templates that were enriched were associated with both VDR and its partner protein at the same time (II, Fig. 6). 
All the regions showed different patterns of partner proteins. The region from -1786 to -2176 recruited VDR-
RXR complex in a 1α,25(OH)2D3-dependent manner. The complex was associated in this region 60 and 240 min 
after ligand treatment. The VDR-NCoA3 complex bound that region constantly, and the binding was increased 
after ligand stimulation. The VDR-MED1 complex was also constantly there showing the strongest association 
after 60 min 1α,25(OH)2D3. VDR-pPol II complex was weakly present without 1α,25(OH)2D3 treatment, but the 
binding of this complex increased notably after ligand treatment. The region form -5,217 to -5,746 bound VDR-
RXR, VDR-NCoA3 and VDR-MED1 complexes with and without 1α,25(OH)2D3 treatment. VDR-RXR and 
VDR-MED1 complexes were slightly increased in a 1α,25(OH)2D3-dependent manner. The VDR-NCoA3 
complex showed the strongest binding after 60 min 1α,25(OH)2D3 stimulation, as did the VDR-pPol II complex. 
The latter complex was not found on the promoter 240 min after 1α,25(OH)2D3 treatment. The region from -
6,782 to -7,202 showed 1α,25(OH)2D3-dependent binding of all complexes. VDR-RXR and VDR-MED1 
complexes were both present without 1α,25(OH)2D3 stimulation, VDR-RXR complexes showed the maximum 
binding after 240 min 1α,25(OH)2D3 treatment and VDR-MED1 after 60 min 1α,25(OH)2D3 treatment. VDR-
NCoA3 and VDR-pPol II complexes associated with the promoter just after 1α,25(OH)2D3 stimulus, the VDR-
NCoA3 complex showed its maximum binding after 60 min 1α,25(OH)2D3 treatment and the VDR-pPolII 
complex only after 240 min incubation with 1α,25(OH)2D3. The binding of VDR and its partner proteins to the 
region ranging from -7,825 to -8,383 was the least responsive to 1α,25(OH)2D3of all four regions. All complexes 
bound the region with and without any stimulus. The VDR-RXR complex was recruited in a 1α,25(OH)2D3-
dependent manner, while the VDR-NCoA3 binding was the strongest after 60 min and diminished to the level of 
untreated samples. The binding of VDR-MED1 and VDR-pPol II complexes were even slightly reduced after 
1α,25(OH)2D3 treatment. The differences in the patterns of partner protein recruitment indicate the individual 
character of the different VDREs of the CYCLIN C promoter. 
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5.3 Integration of RAR- and NF-κB–mediated activation of the human 
HAS2 gene promoter (III) 
 
The first publication of this thesis already indicated that the retinoid-responsiveness of human HAS2 gene is 
complex. The second publication concerning the regulation of the human CYCLIN C gene on the chromatin level 
suggested that the chromatin level mechanisms of gene regulation are unique to each RE. In this study, the 
mechanisms of all-trans RA–mediated activation of the HAS2 gene were studied in more detail. In addition, the 
roles of TFs NF-κB and Sp1 in the regulation of HAS2 gene were assessed. 
 
In silico screening of the human HAS2 promoter revealed in addition to RAREs and STAT-REs also putative 
binding sites for constitutive nuclear factor Sp1 and NF-κB (III, Fig. 1). The net-based program ConSite 
identified with a TF score cutoff of 85 % three putative NF-κB REs at positions -375 to -384 (NF-κB RE1), -
1,417 to -1,426 (NF-κB RE2) and -1,888 to -1,897 (NF-κB RE3) within the first 2,250 bp of human HAS2 
promoter. With the same cutoff of 85 % ConSite identified in total 12 putative Sp1 REs within the same 
promoter region. 
 
To get information on whether the putative elements found in silico are functional and identify the patterns of co-
regulators that they recruit, ChIP assays were performed with 0, 60 and 240 min all-trans RA- and 0 and 60 min 
TNFα-treated HaCaT cells (III, Fig. 2). The association of the MED protein MED1, the CoAs CBP and SRC-1, 
the CoR NCoR1 and the constitutive nuclear factor Sp1 was measured using specific antibodies for respective 
proteins. The different type of co-factors, MED1, CBP, SRC-1 and NCoR1 in addition to Sp1 showed each an 
individual pattern for their stimulation-dependent and -independent association with the HAS2 promoter. All five 
proteins associated to the regions containing NF-κB REs 1 and 3. Interestingly, the RARE cluster containing 
region bound significantly only CBP and Sp1. All-trans RA increased the binding of CBP to the region 
containing the RARE cluster. Similarly, it increased the association of Sp1 to the NF-κB RE1 containing region, 
that of CBP and SRC-1 to the NF-κB RE2 containing region and CBP, MED1, Sp1 and surprisingly also NCoR1 
binding to the NF-κB RE3 containing region. TNFα stimulated the association of SRC-1 to the NF-κB RE 1 
containing region, of CBP and Sp1 to the NF-κB RE3 containing region and Sp1 binding to the NF-κB RE2 
containing region, as well as MED1 binding to the RARE cluster. 
 
The RARE cluster containing region demonstrated all-trans RA-dependent recruitment of co-factors (III, Fig. 
2A). In order to induce transcription, this region must move closer to the TSS of the HAS2 gene by DNA 
looping. Therefore, the chromatin compositions of both the RARE cluster and the TSS containing regions were 
analyzed in further detail (III, Fig. 3A). ChIP analysis were performed with 0, 60 and 240 min all-trans RA 
treated HaCaT cells using antibodies against pPol II, RAR and a known co-regulator involved in RA-mediated 
transcriptional responses, PARP-1. Furthermore, re-ChIP assays were performed with anti-RARγ antibodies in 
combination with antibodies for pPol II, SRC-1, MED1, CBP and NCoR1. pPol II binding was relatively 
constant to the TSS and only marginally detectable on the RARE cluster. Supporting the functionality of the 
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RARE cluster, RAR binding was clearly increased on both regions after all-trans RA treatment. Additionally, 
some weak but ligand-dependent association of PARP-1 to both regions could be detected. RAR-pPol II and 
RAR-SRC-1 complexes were detected on the RARE cluster in all-trans RA-dependent manner. Furthermore, the 
preassembled RAR-NCoR1 complex on the RARE cluster dissociated after ligand addition. Moreover, 
complexes of RAR with SRC-1, MED1, CBP and NCoR1 were detectable on the TSS, but their association was 
not affected significantly by all-trans RA.  
 
ChIP results suggested functionality of HAS2 promoter in response to retinoids, which was further supported by 
reporter gene assays. A nested set of HAS2 promoter constructs was created in the luciferase reporter gene 
containing vector pGL3 (Monslow et al., 2004). The 3’ end of each promoter fragment was located at position 
+43, and the longest insert extended to position -2,118 bp relative to the TSS (III, Fig. 3B). The RARE cluster 
was contained in promoter fragments 11 and 12, which provided a 5.4- and 1.7-fold response to all-trans RA, 
respectively. Shorter promoter fragments showed a drastic loss of basal activity and all-trans RA inducibility. 
Still, promoter fragment 10 was an exception providing a 2.3-fold induction of luciferase activity. However, the 
basal and the stimulated absolute luciferase activity of this promoter fragment were both below that of the basal 
luciferase activity value of the constructs containing the RARE cluster. 
 
As the regions containing the putative NF-κB REs showed responsiveness to TNFα in the recruitment of 
transcriptional co-regulators, the role of NF-κB in the TNFα-mediated activation of the HAS2 promoter was 
further studied. The chromatin composition of all four NF-κB RE containing regions and of the TSS were 
investigated by ChIP analysis with HaCaT cells treated for 0 and 60 min with TNFα using antibodies against 
NF-κB p65 and pPol. Furthermore, re-ChIP assays were performed with anti-NF-κB p65 antibodies in 
combination with antibodies against pPol II, SRC-1, MED1, CBP and NCoR1. pPol II binding could be detected 
only at the TSS and in the region containing the NF-κB RE1. The binding was constitutive in both regions. The 
binding of NF-κB to the NF-κB RE1 containing region was TNFα-inducible, whereas its association to region 
encompassing NF-κB RE2 was weaker but also inducible, and finally, it bound constantly the region containing 
NF-κB RE3. The NF-κB-pPol II complex associated with the TSS and the region containing NF-κB RE3 in a 
clearly ligand-inducible manner, whereas the dominant binding of the complex to the NF-κB RE1 containing 
region was reduced after addition of the ligand. The region containing NF-κB RE2 did not bind significantly any 
of the complexes studied significantly. NF-κB-SRC-1 complex bound to the regions that contain NF-κB REs 1 
and 3. This binding was found to be inducible by TNFα at first but showed decreased binding to the latter RE 
containing the site. NF-κB-MED1 and NF-κB-CBP complexes were found on the both regions possessing the 
same the putative NF-κB REs. The complexes showed the same profile of constant binding to the NF-κB RE1 
containing region and an inducible association with the region containing NF-κB RE3. Finally, on these two NF-
κB REs also some weakly binding TNFα-inducible NF-κB-NCoR1 complex were detected. 
 
The functionality of the three putative NF-κB REs were further tested by reporter gene assays in HaCaT cells 
using the same set of luciferase reporter gene constructs as described earlier (III, Fig. 3B). As reporter gene 
assays traditionally accumulate signals and are not very suited for the measurements of transient stimulations, 
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such as a treatment with TNFα, these assays were focused on the effects of NF-κB on the basal activity of the 
HAS2 promoter by overexpressing the subunits of NF-κB, p50 and p65 (III; Fig. 4B). Promoter fragment 12 
containing all three NF-κB REs was induced 7.3-fold, when p50 and p65 were overexpressed. Under the same 
conditions promoter fragment 11 lacking NF-κB RE3 showed only a 4.5-fold induction and fragment 10 lacking 
both NF-κB REs 3 and 2 did not show any induction. When NF-κB RE1 was isolated from putative upstream 
regulatory elements (fragment 5), a drop of basal activity was observed, which could be restored by p50/p65 
overexpression resulting in a 3.0-fold induction. Finally, the shortest promoter fragments 4 to 1 not containing 
any NF-κB REs showed no significant response to p50/p65 overexpression. 
 
To assess, whether NF-κB binds directly to three putative NF-κB REs on the HAS2 promoter, gel shift assays 
using HaCaT nuclear extracts were performed. The cells were treated for 60 min with 20 ng/ml TNFα, with and 
without 90 min co-treatment with 10 μM IKK-2 inhibitor (III, Fig. 4C). An idealized NF-κB RE served as a 
control, on which TNFα stimulation induced two complexes, which were previously identified as p50-p65 
heterodimers (the lower complex) and p65 homodimers (upper complex) (Urban et al., 1991). p50-p65 
heterodimer binding could be observed on all putative NF-κB REs, while faint p65 homodimer binding could be 
observed in addition to the control RE only on NF-κB RE2. IKK-2 inhibitor treatment of the cells as well as 
incubation of the nuclear extracts with anti-p65 antibody reduced the binding of both types of NF-κB complexes 
to all four isolated NF-κB REs. In this direct comparison, NF-κB RE2 seemed to be the strongest binding 
element in vitro. However, in the functional ChIP assays, NF-κB RE2 did not associate with p65 indicating that 
greater complexities exist in the chromatin environment in vivo.  
 
To support the assumption that HAS2 gene is of larger impact than the other HASes in HaCaT cells, the basal 
activities of all these genes were monitored by real- time quantitative PCR in relation to the control gene RPLP0 
(III, Fig 5A). In fact, the data demonstrated that HAS2 was the predominantly expressed member of the HAS2 
gene family, since it was found to be 30-fold higher expressed than the HAS3 gene and even 10,000-fold more 
prominent than the  HAS1 gene. The basal HAS2 expression was increased 7.4-fold by all-trans RA treatment, 
but only 1.8-fold through TNFα (III, Fig. 5B). The co-treatment with IKK-2 inhibitor abolished the TNFα-
response of the HAS2 gene. Interestingly, it also reduced the all-trans RA induction of the gene down to 3.2-fold. 
 
Taken together, HAS2 was shown to be the dominant HAS gene in HaCaT cells and a primary target of both all-
trans RA and TNFα. Interestingly, a co-treatment of all-trans RA and IKK-2 inhibitor suggested a HAS2-
specific interference of retinoid and NF-κB signaling.  
 
5.4 Comparison of RAR- and CREB–mediated regulation of the human 
genes HAS2 and CYCLIN C (IV) 
 
We showed in the first three publications of this thesis that the regulation of both human HAS2 and CYCLIN C 
genes is complicated. The chromatin compositions of different REs in response to a certain stimuli showed 
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individual characters of chromatin associated proteins. The finding that different signaling pathways could 
integrate by using the same co-regulators even further increased the complexity. In order to get a broader view on 
the mechanisms of gene regulation by different TFs and the integration of different signaling pathways on 
chromatin level the regulation of two different genes, HAS2 and CYCLIN C, was investigated in this study (IV). 
Here we studied the regulation of the two different genes by the TFs CREB1 and RAR, and also their integration. 
 
The basal expression levels of human HAS2 and CYCLIN C genes were measured both in HEK293 and HaCaT 
cells (IV, Fig. 1A). The CYCLIN C gene was more expressed than the HAS2 gene in both cell lines. In HEK293 
cells, CYCLIN C mRNA levels were nearly 30-fold higher than that of the HAS2 gene and in HaCaT cells they 
were still 25-fold higher. In the two different cell lines the two genes showed an individual pattern of inducibility 
by various stimulants. In HEK293 cells the basal HAS2 mRNA expression was increased 2.1-fold by all-trans 
RA treatment compared to total 7.4-fold increase in HaCaT cells (IV, Fig. 1B). The cAMP inducer Forskolin 
increased HAS2 expression 2.7-fold in HaCaT and 3-fold in HEK293 cells after 60 min stimulation and 4.6-fold 
and 7.9-fold after 24 h treatment, respectively. In HaCaT cells all-trans RA combined with 60 min Forskolin 
gave 6.2-fold induction of the HAS2 gene, compared with a 3.6-fold induction in HEK293 cells. Surprisingly, 24 
h Forskolin treatment reduced the all-trans RA effect down to 2.7-fold in HaCaT cells, but increased it to 13.3-
fold in HEK293 cells. All-trans RA induced CYCLIN C mRNA levels only slightly, 1.6-fold in both cell lines. In 
HEK293 cells 60 min Forskolin treatment stimulated CYCLIN C mRNA levels 1.6-fold and the addition of all-
trans RA potentates the induction to 2.9-fold. In HaCaT cells, neither 60 min or 24 h Forskolin treatment nor the 
combinations with all-trans RA affected the mRNA levels significantly. In HEK293 cells 24 h treatment with 
Forskolin induced CYCLIN C mRNA 2.3-fold and the combination with all-trans RA further 2.9-fold. A time 
course experiment with 1, 2, 4, 6 and 24 h time points showed that all-trans RA–mediated induction of the HAS2 
gene showed a similar trend in both cell lines (IV, Fig. 1C). The induction was close to its maximum already 
after 1 h not changing significantly until 24 h when no significant induction was seen. In HaCaT and HEK293 
cells the Forskolin effect was highest after 24 h. In HaCaT cells the combination of all-trans RA and Forskolin 
induced HAS2 mRNA the most after 1 and 2 h and the induction was diminished towards 24 h, whereas in 
HEK293 cells the induction by the combined treatment increased over time having its maximum at 24 h. The 
CYCLIN C gene was induced significantly in HaCaT only after 4 h treatment with all-trans RA. Any of the other 
treatments did not result in a significant change in the mRNA levels. In HEK293 cells, all-trans RA induced 
CYCLIN C mRNA significantly only after 2 h and Forskolin only after 1 and 24 h. The combination of the both 
stimulants resulted in the maximal induction at 24 h. 
 
As both HAS2 and CYCLIN C genes were induced by Forskolin and all-trans RA, the first 2250 bp of both 
promoters were screened in silico for putative RAREs and CREs (IV, Fig. 2). Screening the promoter for two 
copies of RGKTCA consensus sequence in a DR2 and DR5 arrangement identified putative RAREs. The 
maximal deviation from the consensus sequence was restricted to one position. A cluster of two overlapping 
RAREs (position -1,208 to -1,237) have previously been identified and confirmed on HAS2 gene. Two putative 
DR2-type RAREs were found on the CYCLIN C promoter at positions -537 to -550 and at -1,147 to -1,160. 
Putative CREB binding sites were screened by using the net-based program ConSite (http://mordor.cgb.ki.se/cgi-
bin/CONSITE/consite/) with a TF score cutoff of 85 %. Three putative CREs could be identified on the HAS2 
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promoter. They were located at positions -656 to -663, -1,731 to -1,751 and -1,878 to -1,889 relative to the TSS. 
On the CYCLIN C promoter four putative CREs at positions -586 to -595, -844 to -855, -1,970 to -1,981 and -
2,234 to -2,244 were identified. The CYCLIN C promoter contains a lot of repetitive sequences. The CREs 2, 3 
and 4 and the DR2-type RAREs are in repetitive sequence (CRE4 only partly). That means their role as 
functional REs should be considered critically. 
 
The effects of Forskolin and all-trans RA on the recruitment of CREB, RAR, pPol II and transcriptional co-
regulators: MED1, the CoAs CBP and SRC-1, the CoR NCoR1 were studied by screening the first 2250 bp of 
both the HAS2 and the CYCLIN C promoters by ChIP assays with HEK293 cells that were treated for 0 and 60 
min with 0.1 μM all-trans RA or 10 μM Forskolin (Figs. 9 and 10) (IV, Figs. 3A and 3B). All co-regulators, the 
TFs and pPol II had a unique pattern for their stimulation-dependency and timing. RAR bound to the HAS2 
promoter ligand-independently and in both retinoid- and Forskolin-responsive way. Ligand-dependency was seen 
in the regions containing CRE1, the RARE cluster and CRE3. Surprisingly, to all these regions both Forskolin 
and all-trans RA induced the binding of RAR. CREB associated to all regions containing the putative CREs in 
addition to few other regions. Only at the TSS and in the region containing CRE1 there was some ligand-
dependency seen. Again, both Forskolin and all-trans RA induced its binding more or less in a similar fashion. 
Additionally, the binding of pPol II, MED1, CBP and NCoR1 showed both ligand-dependent and -independent 
patterns. In addition, their association to the regions containing CREs was not merely Forskolin-dependent but 
also all-trans RA-dependent in some regions. Vice versa Forskolin was also found to induce the binding of RAR 
to the RAREs indicating interference of the signaling pathways. MED1 binding on the HAS2 promoter showed 
more responsiveness to Forskolin than to all-trans RA, but other regulators did not make a difference between 
Forskolin or all-trans RA. On the CYCLIN C promoter the interference of Forskolin and all-trans RA signaling 
was also seen in a similar fashion as that observed on the HAS2 promoter. RAR bound to regions containing the 
TSS and all CREs, in addition to the region containing the two DR2-type RAREs. CREB1 binding was 
significant only in the region covering CREs 1 and 2 and two DR2-type RAREs and in the region containing the 
CREs 3 and 4 after Forskolin treatment. pPol II associated with the three most closest regions to TSS (covering 
in total the TSS, CREs 1 and 2 and the two DR2-type RAREs) more or less constantly. MED1 associated 
significantly to the region containing the TSS, where its binding was strong even without any stimulus. In the 
region ranging from -1332 to -1845 and not containing any putative RE for the TFs studied all-trans RA 
recruited MED1 binding. CBP bound to the region covering CREs 1 and 2 and two DR2-type REs and in the 
region containing CREs 3 and 4. To both regions it associated in the absence of ligand, but the binding increased 
after Forskolin treatment and even further after all-trans RA stimulation. Without Forskolin or all-trans RA 
treatment NCoR1 was found at the TSS, in the region next to the TSS (from -108 to -363) and in the region 
containing CREs 3 and 4. In the region containing the TSS all-trans RA treatment caused the NCoR1 binding to 
disappear and in region 5 both Forskolin and all-trans RA diminished the binding, with Forskolin pushing even 
below the significance level.  
 
As all putative CRE- and RARE-containing regions showed some responsiveness to both all-trans RA and 
Forskolin, re-ChIP assays were performed to confirm the role of RAR and CREB in the recruitment of co-
regulators to both gene promoters. On the HAS2 promoter the RAR-pPol II complex bound to the RARE cluster 
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in both Forskolin and all-trans RA-dependent manners verifying the functionality of the RARE cluster and 
supporting the idea that RAR and CREB may interfere each other. The RAR-CBP complex bound to the regions 
encompassing CRE1, the region containing the RARE cluster, the regions with CREs 2 and 3 and the region 
containing CRE3 after both Forskolin and all-trans RA stimulation indicating the CBP might be one link 
between Forskolin and retinoid signaling. The RAR-NCoR1 complex associated very weakly with the TSS in the 
absence of ligand disappearing after the addition of either Forskolin or all-trans RA. The CREB-pPol II complex 
was detectable more or less constantly in all regions covering the promoter from -244 to -1048 and containing 
CRE1 and in region having CREs 2 and 3. The CREB-CBP complex was found on the HAS2 promoter only in 
two regions, in the region located at -244 to -481and in the region containing CREs 2 and 3. In both regions 
Forskolin increased the binding. The CREB-MED1 complex showed the highest Forskolin responsiveness to all 
CRE RARE containing regions. 
  
Taken together, both ligands recruited the same co-regulators indicating functional interference but in parallel 
also showed some individual differences. The general features of the recruitment of transcriptional regulators to 
both HAS2 and CYCLIN C promoter in response to different stimulations are depicted in the model (Figs. 9 and 
10, respectively). All-trans RA seemed to regulate mainly NCoR1 association, while Forskolin affected in 
addition to NCoR1 also MED1 and CBP association. The REs differed in response of co-regulator binding after 
the same stimulus. There are indications that on CRE1 MED1 and NCoR1 seem to be the main regulators, 
whereas on CRE2 and CRE3 CBP together with NCoR1 may be central.  
 
 
Fig. 9. Model describing the chromatin composition of CREs and the RARE cluster on the human HAS2 promoter. 
CREs 1, 2 and 3 and the RARE cluster on the Has2 promoter recruit each an individual pattern of co-factors, pPol II and TFs 
in response to all-trans RA, Forskolin or the combination of all-trans RA and Forskolin. 
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On the CYCLIN C promoter the RAR-pPol II complex associated to the region containing CREs 3 and 4 and to 
regions not bearing any putative REs (from – 108 to -363 and from -1332 to -1845) without any stimulus. In the 
region with CREs 3 and 4 its binding was constant. Surprisingly, the complex disappeared from the region 
covering the promoter from -108 to -363 after all-trans RA stimulation and from the region from -1332 to -1845 
after both all-trans RA and Forskolin treatment. All-trans RA recruited the complex to the region with CREs 1 
and 2. The RAR-CBP complex was found at the TSS and in the two regions with no putative REs and in the 
region with CREs 3 and 4. At the TSS and on the region containing CREs 3 and 4, the complex was recruited 
just after Forskolin and all-trans RA stimulation. Forskolin induced the dissociation of the complex from the two 
regions with no putative REs (from -108 to -363 and from -1332 to -1845). All-trans RA had the same effect in 
the region covering the area from -1332 to -1845. RAR-NCoR1 complexes were found merely also in that 
region, where the binding stayed more or less constant. The CREB-pPol II complex was found constantly and 
quite strongly in the regions covering the area from -108 to -363 and the one containing CREs 3 and 4. In the 
region containing the TSS the complex was found only after either Forskolin or all-trans RA treatment. CREB-
CBP complexes associated with region 4 constantly, whereas in the region with CREs 3 and 4 it was found just 
after Forskolin stimulation. It also bound the TSS without ligand, but any stimulus decreased the binding. CREB-
NCoR1 complexes bound very weakly to the region with TSS. In the region with CREs 3 and 4 the binding was 
strong without Forskolin or all-trans RA treatment, but both ligands diminished the binding nearly below the 
significant level.  
 
 
Fig. 10. The chromatin composition of two CYCLIN C promoter fragments. The chromatin composition of the region 
containing CREs 1 and 2 and two DR2-type RAREs is different from the region containing CREs 3 and 4. These two regions 
also recruit different patterns of transcriptional regulators in response to all-trans RA, Forskolin and their combination. 
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In summary, both Forskolin and all-trans RA recruited their TFs, pPol II and co-regulators to CYCLIN C 
promoter regions suggesting response to both Forskolin and all-trans RA (Fig. 10). The REs in repetitive 
sequences must be considered cautiously. That makes the only RE totally in unique sequence, CRE1, to be 
considered as the most critical RE. The role of the two putative DR2-type RAREs in region 3 as the mediator of 
the retinoid-response of the gene is not fully confirmed. Again, NCoR1 and CBP might be the functional co-
regulators of the CYCLIN C promoter.  
 
The functionality of both human HAS2 and CYCLIN C genes in response to retinoids and Forskolin was further 
studied in reporter gene assays (IV, Fig. 4). For that purpose a nested set of HAS2 promoter constructs was 
created in the luciferase reporter gene-containing vector pGL3 (Monslow et al., 2004). The promoter fragments 
were the same than the ones used in the previous publication of this thesis (III). The 3’ end of each promoter 
fragment was located at position +43, and the longest insert extended to position -2118 bp relative to the TSS. 
The RARE cluster was contained in promoter fragments 11 and 12. The CRE1 was contained in fragments 8 to 
12 and CRE2 and CRE3 in fragment 12. Three CYCLIN C promoter fragments were created in the luciferase 
reporter gene-containing vector, pGL4. The 3’ end of all promoter fragments was located at position +25. The 
shortest insert extended to position -149 relative to the TSS, the next fragment to -1,598 covering the unique 
CRE1, CRE2 and the two DR2-type RAREs, and the longest fragment extended to position -2,399 covering all 
four CREs and the two DR2-type RAREs. The effect of RAR on both promoters was studied by overexpressing 
the pSG5-based expression vectors for RARγ and RXRα in HEK293 cells and stimulating the cells with all-trans 
RA, Forskolin and their combination (Fig. 4A, IV). On the HAS2 promoter the highest basal activity was seen in 
the largest fragment containing all three CREs and the RARE cluster. Fragment 11 containing the RARE cluster 
and CRE1 showed the second highest basal activity, though it was not significantly higher than the basal activity 
of the shorter fragments. Fragment 12 was induced by Forskolin 1.8-fold, by all-trans RA 2.2-fold and by their 
combination 1.3-fold, when RAR and RXR were overexpressed. Surprisingly, fragment 8 (containing CRE1) 
showed a significant 1.25-fold repression in response to all-trans RA. On the CYCLIN C promoter constructs, 
retinoid receptor overexpression did not have any effect on the activity of the promoter. However, the combined 
treatment of all-trans RA and Forskolin reduced the activity of the longest fragment 1.25-fold. Interestingly, the 
shortest promoter fragment, containing just the TSS, showed approximately 4-fold higher basal activity than the 
longer ones indicating that there are some repressive elements within the first 2,400 bp of the CYCLIN C 
promoter.  
 
The effects of CREB on both promoters were investigated by overexpressing CREB1 in a pFN2K-based 
expression vector in HEK293 cells and stimulating the cells with all-trans RA, Forskolin and their combination 
(IV, Fig. 4B). The basal activity of the HAS2 promoter started to arise from fragment 8 (CRE1) on the largest 
fragments showing the highest activity. On fragment 4, all-trans RA caused a 1.7-fold repression. Interestingly, 
fragment 5 was induced 3.8-fold in response to retinoids. Also fragment 6 was induced 2.8-fold. Fragment 8, the 
first fragment to contain CRE1, was induced 2.7-fold in response to Forskolin and 1.8-fold in response to all-
trans RA. Fragment 9 was also induced 2.8-fold by Forskolin. Fragment 11, containing the RARE cluster in 
addition to CRE1 was induced 5.1-fold in response to all-trans RA and 3.1-fold in response to combination of 
Forskolin and all-trans RA. The largest fragment, containing now all three CREs and the RARE cluster was 
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induced by Forskolin, all-trans RA and their combination in a similar fashion, approximately 2.5-fold each. The 
shortest fragment of the CYCLIN C did not show any inducibility in response to any of the stimulants, but again, 
it had a much higher basal activity than the longer fragments. The fragment with the two DR2-type RAREs and 
CREs 1 and 2 was induced 1.4-fold in response to Forskolin and 1.9-fold in response to all-trans RA and the 
combination of both individual stimulants. The fragment covering the first 2,399 bp of the CYCLIN C promoter 
was induced by Forskolin 2.2-fold and 2.8-fold by the combination of all-trans RA and Forskolin suggesting the 
functionality of the promoter in response to Forskolin. 
 
The effects of RAR, RXR and CREB on the HAS2 and CYCLIN C promoter activities were also checked by 
transfecting the pFN2K -based expression vector for CREB1 and the pSG5-based expression vectors for RARγ 
and RXRα into HEK293 cells, which were then stimulated with all-trans RA, Forskolin and their combination 
(IV, Fig. 4C). The basal activity of the HAS2 promoter started to arise from fragment 3 on fragment 12 showing 
the maximum. Surprisingly, already fragment 2 was induced significantly by Forskolin and combination of 
Forskolin and all-trans RA, 1.4 and 1.3-fold, respectively. Fragment 5 was induced 1.3-fold and 1.5-fold by 
Forskolin and combination of Forskolin and all-trans RA. Interestingly, fragment 6 was reduced by all-trans RA 
1.7-fold. Fragment 8 that contains CRE1 was induced 1.8-fold by Forskolin, 2-fold by all-trans RA and 2.8-fold 
by the combination indicating interference of retinoids and Forskolin. Fragment 10 was induced significantly by 
the combination of all-trans RA and Forskolin, the induction was 1.7-fold. Fragments 11 and 12 showed 
induction in response to all treatment conditions. Fragment 11 that contains CRE1 and the RARE cluster was 
induced by Forskolin 1.8-fold, by all-trans RA 1.7-fold and by the combination 1.9-fold. In fragment 12 that 
contains in addition to elements in fragment 11, also the CREs 2 and 3, the inductions were 1.6-fold, 1.3-fold and 
1.8-fold, respectively. The CYCLIN C promoter was induced less in response to any stimulant. The shortest 
fragment did not respond to any of the stimulants. The fragment extending to -1,598 from the TSS was induced 
by Forskolin only 1.2-fold, though significantly. The all-trans RA-mediated response was 1.1-fold and the 
combination led to a 1.3-fold stimulation. The longest fragment was induced by Forskolin 1.2-fold and by the 
combination of all-trans RA and Forskolin 1.5-fold. Interestingly, all-trans RA alone reduced the activity 1.25-
fold. Taken together these reporter gene assays indicate an interference of retinoids and CREB signaling on the 
regulation of both the HAS2 and CYCLIN C gene. These results verify the functionality of all CREs and the 
RARE cluster on the HAS2 promoter and also functionality of the CYCLIN C promoter in response to both all 
trans RA and Forskolin. 
 
The interference of Forskolin and all-trans RA was further investigated with ChIP using Forskolin and all-trans 
RA treatment together (Fig. 9 and 10), (IV, Figs. 5A and 5B). Chromatin was extracted from HEK293 cells that 
were stimulated for 0 and 60 min with 0.1 μM all-trans RA and 10 μM Forskolin. ChIP assays were performed 
with antibodies against pPol II, RAR, CREB1, SRC-1, MED1, CBP and NCoR1. Only the regions containing the 
putative REs for CREB and RAR were selected to this study. The ChIP data with the combined treatment 
demonstrated that Forskolin and all-trans RA were interfering with each other. On the HAS2 promoter, MED1, 
CBP and NCoR1 mediated their combined action. The effect of the combined treatment on the HAS2 promoter 
was best seen in CREs 2 and 3 and in the RARE cluster. The effects of the combination were much the same than 
the effects of both treatments alone. The most obvious difference was the recruitment of CBP to the region 
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containing the RARE cluster, where it was not present, when stimulated with Forskolin or all-trans RA alone. On 
the CYCLIN C promoter the combined effects were best seen in the region containing the CREs 1 and 2 and two 
DR2-type RARES, and also at the TSS. The combined treatment showed more differences in case of the 
CYCLIN C gene in the recruitment of transcription regulators compared to individual treatments than in case of 
the HAS2 gene. All-trans RA treatment alone recruited RAR to the region containing the CREs 1 and 2 and two 
DR2-type RAREs and the region with CREs 3 and 4, similarly Forskolin recruited RAR to the latter region. 
When added together, there was no RAR binding to any of the regions. Also CREB1 was recruited to TSS just 
after the combination, neither of the separate regions recruited it. MED1 binding to the region with CREs 1 and 2 
and two DR2-type RAREs was increased just after the combination and surprisingly, the CBP binding that was 
even increased after either Forskolin or all-trans RA to the region with CREs 3 and 4 was gone when the 
stimulants were used in combination. 
 
To confirm the roles of MED1, CBP and NCoR1 to all-trans RA- and Forskolin-mediated responses of both the 
HAS2 and CYCLIN C gene, HEK293 cells were transfected with siRNAs against the genes of these co-regulators 
(IV, Fig. 6). When the MED1 gene was silenced, the all-trans RA-mediated 2.1-fold induction of HAS2 mRNA 
was dropped down to 1.1-fold. Silencing the CBP gene Also diminished the all-trans RA-mediated induction to 
1.7-fold, but this reduction was not considered to be significant. Silencing the NCOR1 gene increased all-trans 
RA-mediated induction of HAS2 mRNA to 3.8-fold. This indicates that MED1 and NCoR1 may be the main co-
regulators in the retinoid-responsiveness of the HAS2 gene. Forskolin induced HAS2 mRNA 3-fold. This 
induction went down to 2.3-fold, when the MED1 gene was silenced and to 1.3-fold, when the CBP gene was 
silenced. Only the CBP gene silencing was significant. NCOR1 gene silencing did not have any effect, indicating 
that CBP is the main co-regulator in the Forskolin-mediated response of the HAS2 gene. All-trans RA induced 
the CYCLIN C gene 1.6-fold. Silencing of the MED1 gene led to a 1.4-fold reduction and silencing of the CBP 
gene to 1.25-fold reduction. However, these reductions were not significant. Additionally, NCOR1 gene silencing 
reduced the activity down to 1.2-fold, but this was not significant either. These results indicate that the all-trans 
RA induction of the CYCLIN C gene is not fully requiring MED1, CBP or NCoR1. Forskolin induced the 
CYCLIN C gene 1.6-fold. This induction went significantly down to 0.9-fold when the MED1 gene was silenced 
and the silencing of NCOR1 led to a 2.4-fold induction indicating MED1 and NCoR1 mediated that Forskolin 
response. Silencing of the CBP gene did not have any significant effect.  
 
In summary, both the HAS2 and the CYCLIN C gene were shown to be responsive to all-trans RA and Forskolin. 
Furthermore, regions containing the putative REs for CREB and RAR in their promoter were shown to be 
functional. All REs recruited proteins involved in the regulation of transcription in response to all-trans RA, 
Forskolin or their combination with a unique pattern. All-trans RA and Forskolin signaling were shown to be 
interfering with each other both on the mRNA and the chromatin level. 
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6. Discussion 
 
6.1. Regulation of the HAS2 gene by all-trans RA and EGF 
 
Hyaluronan concentration regulates epidermal keratinocyte behavior, their proliferation and differentiation, 
which should be in a controlled balance for normal function of epidermis. This balance is disturbed in pathologic 
situations, such as wounding and psoriasis. Malignant transformation of epithelial cells is also frequently 
accompanied by increased hyaluronan production and accumulation (Toole et al., 2002). Thus, understanding of 
the regulation of hyaluronan synthesis in epithelial cells becomes extremely important. Various growth factors 
and hormones regulate hyaluronan concentrations, but before this study, virtually no data has been available on 
the control of hyaluronan synthesis on the chromatin level (Monslow et al., 2004). However, several studies 
indicate that the concentration of hyaluronan in different cells and tissues is best correlated with HAS gene 
expression, and in particular with the HAS2 mRNA levels (Pienimäki et al., 2001; Nishida et al., 1999).  
 
This study demonstrates that HAS2 is a primary EGF and all-trans RA responding gene. Retinoids are widely 
applied in the therapy of various skin diseases, but only a few primary all-trans RA responding genes have been 
established in human keratinocytes (Xiao et al., 1999). The 8-fold induction of HAS2 mRNA only after 2 h 
treatment with all-trans RA (I, Fig. 2B) suggests that HAS2 could be used as a marker for monitoring the 
efficacy of synthetic RAR ligands in pre-clinical trials (Altucci and Gronemeyer, 2001). Also in rat, in REK 
cells, the HAS2 gene was induced my both EGF and all-trans RA, but as the effects were more prominent in 
HaCaT cells, and as there were gaps in the rat sequence, the human HAS2 gene was selected for further studies. 
In order to assess the retinoid- and EGF-responsiveness, the first 10 kB of the human HAS2 gene was screened in 
silico for STAT-REs and DR5-type RAREs. In vitro gel shift assays revealed that out of four putative STAT-REs 
and four putative RAREs found in silico only one STAT-RE approximately 380 bp in front of the TSS (STAT-
RE1) showed direct binding. This observation was confirmed by ChIP analysis. Without any stimulation only the 
region spanning the putative STAT-RE1 associated weakly with non-phosphorylated STAT3. Therefore, the 
inactive form of STAT3 seems to associate its RE weakly even without any stimulus. Still, 60 min of EGF 
treatment increased the binding and induced also the binding of the active form of STAT3, pSTAT3. This 
observation strongly supports the idea that this novel STAT-RE is functional and mediates EGFR activation on 
the HAS2 promoter. However, it is important to have in mind that signaling via STAT is not the only signaling 
cascade that EGFR starts. EGFR signaling can also involve RAS and phospholipase Cγ pathways (Carpenter, 
2000). The latter can also lead to NF-κB activation. The finding that the STAT-RE1 overlays by a putative NF-
κB RE (Monslow et al., 2004, Saavalainen et al., 2007) suggests that both STAT and NF-κB may act co-
ordinately in mediating the strong EGF-responsiveness of the receptor via these two overlapping REs.  
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Even though none of the four found putative RAREs showed direct binding of RAR in vitro, the functionality of 
the RARE cluster composed of RARE1 and RARE2 was demonstrated in reporter gene assay, in which the 
RARE cluster could mediate an all-trans RA-dependent reporter gene induction that was comparable with that of 
the idealized DR5-type RARE. Surprisingly, in ChIP assays, all five investigated RE-containing HAS2 promoter 
regions even without any obvious RARE candidate associated with RAR. However, this does not mean that all 
these regions are functionally important in the mediating of the all-trans RA –dependence of the HAS2 promoter. 
According to the current model of retinoid signaling RARs are only functional in a complex with RXR (Bastien 
and Rochetty-Egly, 2004). As only promoter regions 2 (the RARE cluster in addition to STAT-RE2) and 3 
(STAT-RE3) showed association with RXR, all the other regions could be left out as putative functional sites of 
retinoid signaling. The direct comparison of both regions concerning the association of other proteins important 
in retinoid signaling demonstrated that only the RARE cluster containing region showed a significant, all-trans 
RA -induced association of MED protein and activated Pol II, pPol II. Furthermore, a retinoid-induced opening 
of the chromatin monitored by the levels of histone 4 acetylation could be observed only in region 2. These 
findings together with the RGA results make it likely that the retinoid response of the human HAS2 gene is 
mediated via a larger protein complex containing RARγ, RXRα, CBP, MED proteins and activated Pol II 
associated with this RARE cluster. 
 
The analysis of the all-trans RA-dependent occupation of five RE-containing regions of the HAS2 promoter with 
several nuclear proteins suggested that the RARE cluster-containing region is not the only retinoid-responsive 
region. All-trans RA induced the recruitment of both STAT3 and its phosphorylated form to their binding site in 
region 1 (STAT-RE1). STAT3 and pSTAT3 were also associated in an all-trans RA-dependent manner with 
other regions not containing any putative STAT-RE. As all-trans RA is highly specific to retinoids, it is assumed 
that RAR is the core of these effects. Thus, the HAS2 promoter is likely to be associated with one or several large 
protein complexes that may have Pol II or pPol II as its core linked to TFs, CoAs and MED proteins and also to 
enzymes containing chromatin modulating activity, such as CBP. The chromatin-complexed promoter DNA may 
loop around this protein complex and is fixed at different REs. This explains, how all-trans RA-activated RARs 
may influence other proteins in the complex without the need of direct contact with DNA or the respective 
protein partner.  
 
In conclusion, this study demonstrates that the HAS2 is a primary all-trans RA and EGF-responsive gene. The 
responses are going via a RARE cluster approximately 1200 bp upstream of the TSS and a STAT-RE in the 
proximal promoter of human HAS2 gene.  
 
6.2. The 1α,25(OH)2D3 -response of the CYCLIN C gene 
 
The human CYCLIN C is known to be a primary 1α,25(OH)2D3-responsive gene (Polly et al., 2000). This study 
provides a deeper understanding of the chromatin level events in the regulation of the CYCLIN C gene by 
1α,25(OH)2D3. The CYCLIN C gene is an interesting 1α,25(OH)2D3 responsive gene as its function is not linked 
to the classical endocrine functions of 1α,25(OH)2D3, such as the regulation of calcium homeostasis and bone 
Kuopio Univ. Publ. C. Nat. and Environ. Sci. 221: 1-102 (2007) 70 
Discussion 
 
_____________________________________________________________________________________________________ 
mineralization. Therefore, the regulation of the CYCLIN C gene should provide a more detailed understanding of 
the mechanisms how 1α,25(OH)2D3 regulates cellular functions, such as proliferation, differentiation and 
apoptosis. Still, despite some function in the G0-G1 transition in the cell cycle (Ren and Rollins, 2004), the main 
function of the CYCLIN C gene is considered to being a part of MED complexes suggesting that Cyclin C protein 
regulates the general transcription rate rather than the cell cycle. Therefore, it is possible that the effects of 
Cyclin C on the cell cycle are secondary in nature and derive from an effect on the build up of other products 
involved more intimately in cell cycle regulation. Interestingly, Cyclin C has been reported to be contained only 
in those MED complexes that have a transcriptionally repressive function (Wang et al., 2001). The Cyclin C-
CDK8 complex phosphorylates the C-terminal domain of Pol II (Rickert et al., 1996) and the basal TF TFIIH 
(Akoulitchev, 2000) both phosphorylations terminating the transcription. These two functions of Cyclin C make 
it important to understand its regulation in detail.  
 
This study identified up to four VDREs within the first 8.4 kB of the CYCLIN C promoter. The ChIP assays with 
anti-VDR and anti-RXR antibodies suggested that the CYCLIN C promoter may contain up to five VDREs. 
Combined in silico/in vitro scanning of the first 8.4 kB identified in total four putative VDREs, two of which 
were DR3-type and two DR4-type REs. In order to further check the functionality and the chromatin composition 
of these putative VDREs, Re-ChIP assays were performed in order to find out the VDR-complexes on these 
elements. In this assay, first the anti-VDR antibody and then antibodies against RXR, NCoA3, MED1 and 
phosphorylated Pol II were used for immuno-precipitation. All the regions showed unique patterns of VDR and 
its partner proteins in their relative strength and time scale. All regions showed simultaneous associated of VDR 
with all the partner proteins, and most of them showed ligand-responsiveness. The most regions showed their 
maximum binding at the time point 60 min after 1α,25(OH)2D3 treatment. These findings support the 
functionality of the regions further suggesting that these regions are the VDREs via which the 1α,25(OH)2D3 
responsiveness of the CYCLIN C gene is mediated. 
 
In conclusion, this study provides insight into the regulation of the CYCLIN C gene by 1α,25(OH)2D3. One 
strong and three weaker VDREs were found to bind VDR-RXR heterodimers and complexes of VDR and co-
regulators. In addition, each RE showed an individual pattern of these complexes suggesting that each of the 
VDREs is unique in its response to 1α,25(OH)2D3. Because of the role of the CYCLIN C gene in repression, this 
detailed analysis may help to understand the downregulation of a number of secondary 1α,25(OH)2D3-
responding genes with an impact on cellular growth, differentiation and apoptosis. 
 
6.3. Chromatin level mechanisms of RAR- and NF-κB-mediated regulation 
of the HAS2 gene 
 
In addition to RAREs and STAT-REs identified in the first paper (I), the human Has2 was found to contain also 
binding sites for Sp1 and NF-κB. In silico screening of the first 2,250 bp of the promoter identified three NF-κB-
REs, the functionality of which was demonstrated in HaCaT cells. In addition, in total 12 Sp1 binding sites were 
found within the 2,250 bp upstream of the TSS. NF-κB RE1 at position -380 partially overlaid the STAT3 
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binding site reported in the first paper and may contribute to the known response of the HAS2 gene to EGF. Two 
other NF-κB REs at positions -1,420 and -1,890, also associated with the NF-κB component p65 in living cells. 
However, the NF-κB RE1 showed the strongest response to TNFα stimulation. The TSS showed the most 
prominent recruitment of pPol II, MED and CoA proteins in response to TNFα most likely integrating the 
activity of the three NF-κB REs by DNA looping. The activity of all three NF-κB REs was confirmed by 
reporter gene assay. Interestingly, promoter region between -640 and -512 bp showed an inhibitory effect of NF-
κB activity on RE1 according to reporter gene assays. In addition, ChIP assays demonstrated strong NCoR1 
association that was responsive to TNFα. As TNFα has pleiotropic actions, it may affect the HAS2 gene both 
positively and negatively. This may explain why the HAS2 gene is induced by TNFα only 1.8-fold even though 
its promoter contains three functional NF-κB REs. 
 
The RARE cluster at position -1208 to -1226 was found to be the main region responsible for the all-trans RA –
induction of the HAS2 gene. In addition to showing the binding of RAR to the respective promoter region by 
ChIP assay, all-trans RA-dependent recruitment of CBP and Sp1 proteins and dissociation of NCoR1 to the same 
promoter region could be seen. As the ChIP method has its limitations concerning the resolution, some retinoid-
responsive effects were seen also in regions flanking the RARE cluster. RAR can associate with sites in the 
vicinity of the RARE cluster, maybe without direct DNA contact in conjunction with other TFs. This idea is 
further supported by reporter gene assay that showed all-trans RA-dependent activation in the region between 
positions -1,129 and -930. 
 
The constitutive nuclear factor Sp1 appeared to act not only as a constitutive TF but also as a co-factor of both 
retinoid and NF-κB signaling. Therefore, Sp1 is thought to contribute both to the basal mRNA expression of the 
HAS2 gene as well as to its induction by all-trans RA and TNFα. The latter is supported by the observation that 
Sp1 is known to interact with CBP (Song et al., 2002; Zhang et al., 2001). As CBP interacts with many TFs, 
including NRs, such as RARs, and NF-κB (Chen and Greene, 2003), it is well suited to integrate the actions of 
these regulatory proteins. A similar role could be also played by CoA, CoR and MED proteins, as their 
interaction domain do not require very strict target recognition.  
 
A co-stimulation of TNFα and all-trans RA did not have any additional effect on HAS2 mRNA expression. 
However, all-trans RA stimulation was reduced by the application of a NF-κB inhibitor indicating that RAR and 
NF-κB signaling do have interactions. This interference might happen in several levels. Firstly, it can be due to 
the co-operative action of both TFs on the chromatin organization of the same promoter region. Secondly, RAR 
and NF-κB can share common co-factors as suggested in this study. Finally, the interference might be on the 
level of modulating of target gene mRNA stability and the communication of RAR and NF-κB with other signal 
transduction pathways. 
 
Taken together, this study describes the human HAS2 gene promoter being under the control of the inducible TFs 
NF-κB and RAR and constitutively active factor Sp1. These regulatory proteins are thought to share common co-
factors providing numerous possibilities for functional interactions between the different signaling pathways. 
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6.4. Comparisons of the regulation of the genes HAS2 and CYCLIN C by 
Forskolin and all-trans RA 
 
The regulation of the two genes, human HAS2 and CYCLIN C have not been studied in detailed so far (Monslow 
et al., 2004; Saavalainen et al., 2005 and 2007; Sinkkonen et al., 2005). Also the complete picture of the 
regulation of gene expression on chromatin level in general is still unclear becoming an important aspect of the 
research in molecular biology. The altered amounts of hyaluronan are associated with many pathological 
situations including wounding and psoriasis in addition to several inflammatory conditions and malignant 
tumours. As it is also known that the hyaluronan concentration is best correlated with HAS2 gene transcription, 
(Tammi et al., 2005; Pienimäki et al., 2001; Nishida et al., 1999; Karvinen et al., 2003) a detailed understanding 
of the regulation of the HAS2 gene is extremely important. CYCLIN C has also important roles both in normal 
physiology and in disease being a regulator of cell cycle (Ren and Rollins, 2004) and a component of the MED 
complexes. 
 
This study extends our previous studies (I, II and III) concerning HAS2 and CYCLIN C gene regulation 
(Saavalainen et al., 2005 and 2007, Sinkkonen et al., 2005) and provides the regulation by Forskolin and 
combination of all-trans RA and Forskolin as a new aspect.  
 
In silico screening within the first 2,250 bp yielded three and four putative CREs on the HAS2 and CYCLIN C 
promoters, respectively, and a cluster of two RAREs on the HAS2 promoter and two DR2-type RAREs that are 
responsible for the all-trans RA-mediated response of the CYCLIN C promoter. The HAS2 promoter was shown 
to bind many transcriptional regulators in an all-trans RA or Forskolin–dependent manner. Both responses 
showed some independent features but also interference in their signaling. The interference of all-trans RA with 
Forskolin signaling has been demonstrated earlier and might be due to the non-classical action of RA by 
activating CREB1 via PKC, ERK or RSK without RAR (Aggarwal et al., 2006). This study indicates that the 
interference might be, at least in partly, due to common co-regulator recruitment. Many co-factors are rather 
promiscuous in their interaction with TFs. MED1, CBP, SRC-1and NCoR all interact both with CREB1 and 
RARγ. Their short interaction domains do not require very specific target recognition making these co-factors 
suitable for integrating the actions of basically all TFs that they interact with. This general mechanism is 
supposed to apply to all genes that contain functional CREs and RAREs in their regulatory regions making HAS2 
and CYCLIN C only as representative examples. 
 
All putative REs showed a unique pattern of TF and co-regulator binding in response to different treatment 
conditions. There was also quite a lot of ligand-independent association of TFs and co-regulators to the HAS2 
promoter making the chromatin level mechanisms of the regulation of the HAS2 gene complex (Fig. 9). In the 
absence of any stimulus the RARE cluster associated with NCoR1. Also CBP and pPol II to some extent 
associated with this region. The surprising finding that both a CoA and a CoR associated to the same region was 
probably due to looping of the DNA that cannot be avoided in a ChIP protocol using sonicated DNA fragments. 
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In this protocol the average size of the chromatin fragments ranges from 300 to 1000 bp limiting the resolution of 
the promoter scanning. All-trans RA induced RAR association to the RARE cluster, as well as NCoR1 
dissociation from the same region. Also pPol II associated more strongly than without any treatment. 
Interestingly, CBP alone was not immunoprecipitated to this region, but the combination of CBP with pPol II 
was found in the RARE cluster. This indicates that there might be some factor “X” masking CBP and the 
interaction with RAR overcomes this masking. Forskolin treatment recruited RAR to the RARE cluster. It did 
not induce NCoR1 dissociation but increased pPol II binding. Also CBP was bound to this region. The 
association of both NCoR1 and CBP suggests that there is a bigger complex of regulators involved in this region. 
The combination of all-trans RA and Forskolin treatments did not induce significant RAR binding to its RE even 
though it caused NCoR1 to dissociate from this region. Surprisingly, the combination recruited CREB to this 
region although either of the separate treatments did not cause any CREB binding. This might also be due to the 
chromatin looping and association with CBP that still binds the RARE.  
 
CRE1 on the HAS2 promoter harvested a wide range of factors in the absence of any stimulus. It bound NCoR1 
and CREB1 and also showed some association with RAR, CBP, MED1 and pPol II. The association of CREB1 
without ligand stimulation has been proved earlier (Hagiwara et al., 1993; Richards et al., 1996; Gonzalez and 
Montminy, 1989). It is assumed that the regulation of CREB activity happens mainly by regulating CBP 
recruitment rather than CREB binding to CRE. All-trans RA increased RAR binding and also MED1 binding 
and caused NCoR1 to dissociate from the promoter. The increase in the binding of RAR was again probably due 
to looping of chromatin. Forskolin induced MED1 and CBP binding, which was logic, as CBP should be the 
main regulator of CREB binding. Forskolin caused also NCoR1 dissociation from CRE1. The combined 
treatment of all-trans RA and Forskolin caused a similar pattern to CRE1 than Forskolin alone highlighting the 
role of Forskolin as the regulator via this RE. 
 
As CREs 2 and 3 were relatively close to each other (-1,731 to -1,751 and -1,878 to -1,889) and as there are 
limitations in the resolution of ChIP method CREs 2 and 3 were combined in the model (Fig. 9). In the absence 
of ligand there were NCoR1, CBP, MED1 and again CREB binding. All-trans RA recruited pPol II and RAR 
there but did not affect the binding of NCoR1. Forskolin, on the other hand, caused NCoR1 dissociation and 
recruited in addition to MED1 also RAR there. Surprisingly, the combined treatment did not cause RAR 
association even though both separate treatments did.  
 
The CYCLIN C promoter also bound many transcriptional regulators in an all-trans RA- or Forskolin-dependent 
manner. The conclusions concerning the chromatin level events on the CYCLIN C promoter are quite complex 
because of the fact that all other putative REs are at least partly in repetitive sequence except for CRE1. This 
raises CRE1 as the most potent RE concerning the Forskolin response of the CYCLIN C gene. The 
responsiveness to retinoids is even far more complex. The first 2,250 bp of the promoter did not contain any 
putative DR5-type REs or even DR1-type REs that could bind RAR. Even scanning a few thousand bp further 
upstream did not provide any putative RAREs. Anyway, two DR2-type RAREs that were in the repetitive 
sequence were found on the CYCLIN C promoter. Laperriere and co-workers (Laperriere et al., 2007) noticed 
that DR2-type REs elements in Alu sequences were functional RAREs. Without any stimulant, the region 
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containing both DR2-type RAREs in addition to CREs 1 and 2 showed association with RAR and CREB1 (Fig. 
10). Also CBP and pPol II were found in this region. All-trans RA increased RAR binding supporting the idea 
that something within this fragment serves as a RARE (most likely either or both of the DR2s). Otherwise the 
chromatin composition remained the same as without any stimulants. The combination of all-trans RA and 
Forskolin increased CREB1 and pPol II binding. The fact that CBP, CREB1 and also pPol II were found in this 
region suggests that this fragment is also functional concerning Forskolin signaling.  
 
The putative CREs 3 and 4 containing region of the CYCLIN C promoter was found out to be even more 
complicated. In the absence of any stimulus NCoR1, CBP and RAR where associated with this region indicating 
the presence of a bigger complex with also some other proteins involved. Significant CREB1 binding was not 
seen. All-trans RA diminished NCoR1 binding and recruited pPol II indicating that this region although not 
having any RAREs is also functional concerning retinoid-response. Forskolin also recruited pPol II and caused 
the dissociation of NCoR1 in addition to recruiting CREB1 indicating that both or either of the CREs is 
functional. Surprisingly, the combined treatment did not recruit CREB1 or pPol II indicating some kind of 
interference of all-trans RA and Forskolin with each other. 
 
Even though each RE seemed to recruit to some extent an individual pattern of co-regulators, some patterns of 
the recruitment in response to certain stimulus was seen. RNA silencing results confirmed that mainly MED1 
and NCoR1 mediated the retinoid-responsiveness of the HAS2 gene. The Forskolin-responsiveness, on the other 
hand, was mediated mostly by CBP. MED1 and NCoR1 were shown to be the main co-regulators involved in the 
Forskolin-responsiveness of the CYCLIN C gene, while none of the co-regulators investigated was shown to 
affect significantly the retinoid-responsiveness of the CYCLIN C gene. As there are clear differences in the use of 
co-regulators between different genes, the responses of each individual gene are most likely a mixture of general 
and gene-specific mechanisms, how co-factors interfere signalling pathways. 
 
Taken together, this study demonstrated that both human HAS2 and CYCLIN C genes are regulated by all-trans 
RA and Forskolin. On the HAS2 promoter the RARE cluster could be confirmed as the mediator of retinoid-
response. In addition, three CREs were shown to be functional concerning the CREB-response. On the human 
CYCLIN C promoter it can be strongly assumed that the retinoid-response goes via both or either of the two 
DR2-type REs and the CREB-response via the CRE1 in unique region, although the existence of RAREs more 
distant from the TSS cannot be ruled out. All REs showed different patterns of co-regulators in response to 
different stimulus indicating that RAR and CREB signaling pathways differ from each other by the use of co-
regulators. On the other hand, the interference of the two signaling pathways is also likely to happen via the use 
of common co-regulators.  
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7. Summary and conclusions 
 
In conclusion, the four publications, on which this thesis is based, represent a detailed analysis of the chromatin 
level mechanisms of the regulation of human genes HAS2 and CYCLIN C. RAR-, STAT-, NF-κB- and CREB-
mediated regulation of HAS2 gene was investigated. In addition, the chromatin composition of the VDREs on the 
CYCLIN C promoter, as well as its regulation by RAR and CREB was studied.  
 
Regulation of HAS2 gene by all-trans RA and EGF (I) 
This study indicates that both the rat and human HAS2 genes are primary EGF and all-trans RA responding 
genes. However, the details of the mechanisms differ between the two species. The human HAS2 gene contains a 
functional STAT-RE in its proximal promoter. This STAT-RE binds both STAT and the active phosphorylated 
form of STAT in an EGF-responsive way, indicating strongly that it mediates the effects of EGF on the 
regulation of HAS2 gene. A cluster of two RAREs approximately 1,200 bp upstream of the TSS mediates the 
retinoid response of the human HAS2 gene. 
 
Chromatin composition of the VDREs on human CYCLIN C gene in response to 1α,25(OH)2D3(II) 
In this study, the details of the 1α,25(OH)2D3-response of human CYCLIN C gene were studied on chromatin 
level. The first 10 kB of the CYCLIN C promoter contains in total four functional VDREs. The association 
pattern of VDR and its partner proteins, the heterodimerization partner RXR, the CoA NCoA3, MED and 
activated Pol II is different in each VDRE. All four VDREs bind a complex containing VDR and the partner 
proteins in a 1α,25(OH)2D3-dependent way. The intensity and the timing of binding differ between the elements 
making each VDRE unique in the recruitment of VDR and other proteins involved in the regulation of 
transcription. 
 
Integration of the activation of human HAS2 gene by RAR and NF-κB (III) 
The chromatin level mechanisms of the activation of human HAS2 gene by both RAR and NF-κB and the 
integration of the two signaling pathways were investigated in this study. The HAS2 gene promoter was found to 
be under the control of the inducible TFs RAR and NF-κB and the constitutive active factor Sp1. The HAS2 
promoter contains three functional NF-κB REs within the first 2250 bp of the promoter. All three NF-κB REs 
associate with NF-κB and recruit pPol II and transcriptional co-regulators in response to TNFα and also 
constitutively each RE having still a unique pattern of proteins involved in transcription. The RARE cluster on 
the HAS2 promoter associates with RAR, CBP and Sp1 in a retinoid-dependent way. Also NCoR1 is dissociated 
from that region in response to all-trans RA. Sp1 affects both the retinoid and NF-κB signaling in addition to 
being a constitutive TF also by acting as co-factor for both signaling pathways probably via interaction with 
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CoAs, CoRs or MED proteins. As all three regulatory proteins affect the activation of the HAS2 gene and its 
chromatin composition, they are likely to act by sharing common co-factors, which provide numerous 
possibilities for functional interactions between the signaling pathways, of which they are the end point. 
 
Comparison of RAR and CREB-mediated regulation of the HAS2 and CYCLIN C genes (IV) 
This study investigated the chromatin level mechanisms of the HAS2 and CYCLIN C genes by RAR, and 
CREB1. Additionally, the interference of the two signaling pathways was studied. It was demonstrated here that 
both the HAS2 and CYCLIN C genes are regulated by all-trans RA and Forskolin. On the HAS2 the retinoid-
responsiveness goes via the RARE cluster. In addition, three CREs were shown to be functional concerning the 
CREB-response. On the CYCLIN C promoter the retinoid-response is supposed to go via both or either of the two 
DR2-type RAREs and the CREB-response via the CRE1 in unique region. On both promoters both signaling 
pathways have some independent features but they also show some interference. Each RE recruits a different 
pattern of co-regulators making them unique. 
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8. Future aspects 
 
Each cell of an organism contains the same genetic material and the differences between cells arise from 
differences in gene expression. The genome sequences of many organisms have now been completed, which 
raises the mechanisms of gene expression to be the next important aspect in genomics. Recent fast improving 
technologies in the field of bioinformatics and molecular biology in general have provided enormous amounts of 
data that are useful in clarifying the regulatory mechanisms of genes. However, there is not a complete 
understanding of either the regulatory regions or the regulatory proteins involved in the process. Furthermore, the 
dynamics of the process are still poorly characterized. 
 
The genomic data has revealed a huge number of genes with clinical phenotypes. In case of monogenic disorders, 
the disease is due to mutations, mostly in the protein coding sequence of the gene. However, it is now widely 
accepted that the defects in the highly regulated events of gene regulation can disrupt normal gene function and 
lead to pathological states. Knowing the susceptible genes for common diseases, such as cancer, type 2 diabetes 
and Alzheimer’s, is the first step in the fight against the disease. The challenge in the future is not only to 
understand that certain gene is regulated by certain compound but also have a chromatin level understanding of 
the mechanisms by which the process of that gene’s transcription occurs. This provides us a multitude of 
potential target molecules on which to attack, if we want to affect the expression of the gene. We do not have to 
target necessarily always the TF that is known to regulate the gene but the targets could also be the other proteins 
involved in the processes leading to gene expression. A complete picture of the whole process with the 
regulatory regions and the regulators as such enable us to specify the treatments for each patient. In addition the 
increasing number of potential targets makes it possible to overcome the putative side effects of one compound.  
 
It will be very challenging to find a general model on chromatin level events leading to gene expression that 
could be applied to all or at least to most of the signaling pathways. Due to the high diversity of the signaling 
routes, it is easy to speculate that those events do not fit into one model. However, understanding the principles 
of the chromatin level regulation serves as a building block, on which to develop the understanding of 
physiological states. 
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